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ABSTRACT 
To examine the phylogeny, biochemistry and molecular biology of insulin-like 
growth factor (IGF) in local fish species, we started our studies using a local tropical 
fish, the common carp {Cyprinus caripo). We have demonstrated that IGF-I Ea2 form 
is the predominantly expressed form ofIGF in common carp. 
Li the present study, common carp was used to study the molecular biology of 
IGFs with a view to elucidate their genomic structure and expression in liver in 
response to growth hormone (GH). The promoter of the common carp IGF-I gene was 
cloned from carp genomic DNA using polymerase chain reaction (PCR) and this clone 
carries an insert of 840 basepair encompassing the 5'-UTR and part of the signal 
peptide. Ten IGF-I gene related clones from a common carp genomic library were 
isolated after screening of 600,000 plaques. One clone carries an insert of � 1 3 kb and 
probably contains the entire common carp IGF-I gene. Using reverse transcription-
PCR, the hepatic IGF-I mRNA level was found to be elevated after i.p. injection of 
GH at a dose of 100 ng/g body weight. With an aim to search for IGF-H, trout IGF-H 
cDNA was used as a probe to investigate the common carp genomic DNA but no IGF-
n gene were identified in the common carp genomic DNA using Southern blot 
analysis. 
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CHAPTER 1 EVTRODUCTION 
1.1 General Introduction 
Growth is one of the fundamental characteristics of all living organisms. A 
large number ofpeptide growth factors contribute to the stimulation and regulation of 
growth. Like other multifunctional growth factors, insulin-like growth factors I and H 
(IGF-I and IGF-H) elicit diverse effects on a variety ofbiological processes and have a 
broad range of functions on the embryo, fetus, and adult. The action of insulin-like 
growth factors (IGFs) is initiated upon binding to cell-surface receptors and is 
modulated through interactions with secreted IGF binding proteins (IGFBPs). 
The term IGF was proposed to denote peptides which are structurally similar 
to proinsulin (e.g. 50% amino acid sequence homology) but functionally distinct from 
proinsulin. The significant differences between these two molecules are: 1) insulin 
levels fluctuate widely in response to variations in carbohydrate intake; 2) the 
circulating IGFs bound to carrier proteins with stable plasma concentrations; 3) the 
insulin and IGFs posses structurally distinct receptors; 4) insulin stimulates glucose 
transport and metabolic processes, such as glycogen and lipid synthesis, whereas IGFs 
stimulate cellular replication (Clemmons, 1989). These functional and structural 
distinctions appear to be very important for the maintenance of normal carbohydrate 
homeostasis and long-term growth. 
It is believed that IGFs are members of a evolutionarily insulin-related gene 
family which includes insulin, IGF-I, IGF-H, relaxin, insect prothoracicotrophic 
hormone, and molluscan insulin-related peptide (Blundell and Humbel, 1980; Smit et 
al.,‘ 1989). The prevailing theory on the evolution of this family suggests that an 
“early，，insulin-like gene duplication gave rise to the "primary" family members 
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including modem insulin and IGF-I, and that IGF-I and IGF-E diverged during the 
evolution of mammals OFroesch et aL, 1985). However, other taxonomically more 
extensive studies detected IGF-I and IGF-E in birds, reptiles, amphibians, and fish, 
leading to the proposition that the gene duplication event leading to two IGFs 
occurred early in vertebrate evolution (Shamblott and Chen, 1992; Reinecke et al., 
1995). 
Although IGFs have been identified, at either the protein or nucleic acid level, 
in a number of non-mammalian vertebrates including chicken (Darling and Brickell, 
1996)，Xenopus OReinecke et al., 1995), rainbow trout (Shamblott and Chen, 1992)， 
and seabream (Duguay et al., 1996), most studies directed at the identification ofIGFs 
and the elucidation of their biological roles have been restricted to mammalian models 
such as the rat, mouse, and human. As a result of these studies, several generalities 
can be concluded regarding mammalian IGF structure and biological roles. (1) Two 
distinct IGF mRNAs resulting from transcription of separate and unlinked genes are 
present. (2) IGF-I is primarily produced in the liver under the regulation of growth 
hormone (GH) and tends to increase in level from birth to puberty. (3) IGF-E is 
primarily produced in the liver under the regulation of placental lactogen during 
embryonic and neonatal stages of development. (4) Transcription of both IGFs can be 
detected in a wide variety of cell and tissue types. (5) IGF-I and IGF-H undergo 
proteolytic cleavage to generate their mature peptides. (6) The IGF-I gene is subject to 
differential RNA processing to yield two distinct mRNA types but apparently only one 
mature peptide form. (7) Nutritional status, or the supply of dietary energy and 
proteins are important regulators of IGFs. IGFs appear to provide an important 
mechanism linking nutrition and growth (Humbel, 1990; Ketelslegers et al., 1995). 
2 
Although significant accomplishments have been made in the genetics and 
biology of mammalian IGFs, the fact that both the greatest diversity and biomass of 
life on earth is not represented by mammals suggests there is a great deal to be learned 
about all facets of biology, including the regulatory processes of growth, from non-
mammalian models. Until recently, IGFs have been identified and characterized in a 
limited number of nonmammalian species. Since both IGF-I and IGF-E mRNA are 
found in adult and juvenile fish species, it was suggested that both IGF-I and IGF-H 
may have growth effects in teleost (Shamblott and Chen, 1992; Duguay et al., 1996). 
However, most of the studies are focused on the salmonids species, like sahnon and 
trout, which live in temperate water with slow growth rate. Whether this phenomenon 
is universally true for other fish species, particularly those in tropical waters, remains 
to be established, ln order to expand what is known about fish IGFs, we use common 
carp {Cyprinus carpid) as a tropical water fish model to study the molecular biology 
offish IGFs. 
1.2 Historical Overview 
1.2.1 Insulin-Like Growth Factors I and H 
Studies on IGF were started in three separate areas of biomedical research: (1) 
investigation into the actions of GH on growth, (2) studies on the insulin-like effects 
of components of serum, and (3) assessment of the role of locally secreted factors on 
cell replication (Froesch et al., 1963; Daughaday et aL, 1972; Pierson and Temin, 
1972). 
Licreasing the width of the epiphysial cartilage plate of the tibia has long been 
used as an assay for GH. Li 1957, Sahnon and Daughaday found that the effects of GH 
on cartilage growth in rat occurred though a serum factor, initially designated as 
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"sulfation factor” because their assay monitored incorporation of radiolabeled sulfate 
into the extracellular matrix. Licorporation of [^^S]sulfate into cartilage is markedly 
suppressed in hypophysectomized rats and can be stored to normal level within 24 
hours by the administration of GH in vivo. However, the incorporation of [^^S]sulfate 
into cartilage could not be corrected by addition of GH to media containing cartilage 
segments in vitro. It was found that the addition of diluted normal rat serum but not 
from hypophysetomized rat was able to stimulate increase in sulfate uptake of the 
cartilage in vitro (Sahnon and Daughaday, 1957). These experiments showed that 
there must be some intermediary substance(s) mediating the action of GH. This 
sulfation factor which was subsequently termed "somatomedin C" (Daughaday et al., 
1972), was ultimately shown to be IGF-L This hypothesis, commonly referred to as 
the somatomedin hypothesis, has been extensively confirmed and recently extended to 
include autocrine and paracrine roles of somatomedins in many tissues as well as the 
originally recognized endocrine role of this growth factor. 
In the 1960s, several laboratories sought to identify components in serum with 
insulin-like effects on metabolism that were not neutralized by anti-insulin antibodies 
(Froesch et al., 1963; Megyesi et al., 1974). These substance became known as 
nonsuppressible insulin-like activity and ultimately were shown to include both IGF-I 
and IGF-n. 
Li the early 1970s, Pierson and Temin observed that cultured liver cells could 
secrete their own "multiplication-stimulating activity" that enhance cell replication 
(Pierson and Temin, 1972). This factor was later identified as IGF-H (Rinderknecht 
and Humbel, 1978b). 
Liitial attempts to purify these factors suggested that they had overlapping 
activities. With the purification and sequencing of human IGF-I and IGF-H in the late 
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1970s, two peptides containing three disulfide bridges, both with relative molecular 
mass (Mr) of 7,500 were identified. It was found that IGF-I was a single-chain basic 
protein of 70 amino acids and that IGF-E was a slightly acidic single-chain peptide of 
67 residues (Rinderknecht and Humbel, 1978a; Rinderknecht and Humbel, 1978b). 
The amino acid sequences ofIGF-I and -H are � 7 0 % identical to one another, but their 
A and B domains are only � 5 0 % identical to the A and B domains ofhuman insulin. 
Comparsion of the primary sequences of IGFs with insulin allows recognition 
of peptide domains B, C, A, and D, in which domains A and B are structural 
homology to the insulin A and B chains. Domain C is analogous to the connecting (C) 
peptide in proinsulin, whereas the D domain is not found in insulin. Both IGFs are 
synthesized as precursors composed of a signal peptide, the mature peptide, and a 
trailer E domain, in which the signal peptide and E domain are removed during 
posttranslational processing (Fig. 1.1). Although neither the physiological significance 
or the universality of E domain proteolytic cleavage has been established, roles in 
peptide processing, transport, secretion, degradation, receptor interactions, or binding 
protein interactions have been postulated (Lowe, 1996). 
1.2.2 IGF Receptors 
With the availability of highly purified IGFs in the mid 1970s, researchers 
performed cell surface binding assays to examine whether these ligands interacted 
with the insulin receptor (Marshall et al., 1974). It was soon shown that iodinated 
IGF-I bound to cell surface receptor that was distinct from the insulin receptor 
(Megyesi et al., 1975). Li 1980，the second receptor was identified that preferentially 
bind with IGF-E (Rechler et aL, 1980). The subsequent purification of each of these 
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Fig. 1.1 Proteolytic processing of insulin and IGF. Approximate cleavage 
locations are indicated by arrows. The IGF and insulin regions are indicated and 
termed with historic nomenclature (chains and domains). The diagrams below each 
arrow depict the fates and relationships of the domains after cleavage. Liter- and intra-
chain disulfide bonds are indicated by bold lines (Lowe, 1996). 
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receptors and cloning of their cDNAs demonstrated that each was the distinct product 
of a unique gene (Macdonald et al., 1988; Morgan et aL, 1987; Ullrich et al., 1986). 
1.2.3 IGF Binding Proteins 
Unlike insulin, circulating IGFs are bound to carrier proteins, now known as 
IGFBPs. The first indication of the existence ofIGFBPs came in the mid 1970s, when 
it was shown that radioiodinated IGFs complexed with serum proteins, resulting in 
recovery after neutral chromatography ofIGFs in the molecular massed in the range of 
50-150 kDa but not 7.5 kDa (Zapf et aL, 1975). It was soon suggested that these 
serum carrier proteins had at least two functions: prolongation of the half-life of 
circulating IGFs and neutralization of their metabolic effects (Zapf et aL, 1979). 
Through protein purification and cloning experiments, it is now known that the 
IGFBP family comprises at least six members and a variety of functions have been 
ascribed to these proteins (Bach and Rechler, 1995; Baxter, 1993; Jones and 
Clemmons, 1995). 
1.3 Origin and Production of IGFs 
1.3.1 The Hypothalamo-Pituitary-GH-IGF-I Axis 
The hypothalamus produces GH releasing hormone (GHRH) and somatostatin 
(SRJF).The hormones together modulate the secretion of GH so that it is released in 
pulses from the pituitary (Fig. 1.2). GHRH induces GH secretion while SHER inhibits 
GH secretion. The pulsatility of GH release seems to be essential for normal growth 
(Rees and Maxwell, 1996). 
Approximately half of the circulating GH is bound to a specific high affinity 
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Fig. 1.2 Overview ofthe hypothalamo-pituitary-GH-IGF-I axis. 
8 
that are identical to the extracellular GH-binding domain of the GH receptor (GHR) 
and it is thought that GHBP arises by proteolytic cleavage from the GHR. The avidity 
and specificity of GHBP is similar to that of GHR itself. It is thought, therefore, that 
GHBP may reflect GHR activity (Rosenfeld et aL, 1994). Besides modulating the 
interactions of GH with tissue receptors, GHBP holds the pulse of GH in the 
circulation and in the extracellular space and decrease clearance (Rosenfeld et al., 
1994). 
Upon the binding of GH to the GHR, IGF-I production is stimulated. Initially, 
no concentrated tissue source could be discovered, but it was subsequently recognized 
that the liver was the primary source of circulating IGF-I. IGF-I produced in the liver 
is transported to various target tissue by IGFBPs through the circulation. The peptide 
appeared to function, therefore, as a classic endocrine hormone, produced in one place 
(in this case, the liver) and carried in the circulation to distinct sites of action. 
However, IGFs are also expressed in a variety of tissues, including heart, lung, kidney 
and skeletal muscle, where they can act in a paracrine and autocrine fashion in 
response to GH (Lowe, 1996; Rees and Maxwell, 1996). The autocrine and paracrine 
action of IGFs are proposed to have a role in organ specific growth, while endocrine 
IGFs are proposed to participate in the integrated whole-body growth. Circulating 
IGF-I may also feed back at the pituitary and hypothalamus level to inhibit GH 
secretion. 
1.3.2 Factors Regulating IGF Production 
GH sufficiency is not the only factor responsible for regulating IGF-I 
production, for it depends on other factors such as an appropriate nutritional status. 
Uncontrolled diabetes is associated with decreased IGF-I production, and this 
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contributes to the growth abnormalities observed in children with poorly controlled 
diabetes (Lolaczynski and Caro, 1994). Chronic undernutrition leads to reduced serum 
IGF-I. Makiutrition and diabetes, like GH, affect IGF-I production in many tissues. 
Even though GH secretion is altered by malnutrition and diabetes, treatment with GH 
is not able to correct these defects. Decreased IGF-I production secondary to 
nutritional deficiencies appears to reflect alterations in GH sensitivity. Studies showed 
that nutrient availability regulates GH action at multiple levels: liver GHR regulation, 
GH postreceptor events, and IGF-I gene expression. Protein deprivation also 
accelerates IGF-I clearance, modifies IGF-I interaction with binding proteins, and 
attenuates expression ofbiological actions ofIGF-I (Ketelslegers et al” 1995; Thissen 
etal., 1994). 
IGF-I expression is also developmentally regulated. However, fetal 
development is GH independent, so the developmental regulation of IGF-I expression 
in fetal and neonatal animals is secondary to factors other than GH. Hepatic 
production and circulating levels of IGF-I decline with age, primarily because of 
decreased GH secretion OHumbel，1990). 
La addition to GH and nutrition, there are other tissue-specific factors that play 
a part in regulating IGF-I production. For example, gonadotropins and sex steroids 
regulate IGF-I expression in uterus, ovary, and testis (Mauras et al., 1996). Li the 
skeletal system, estrogen, and parathyroid hormone are able to regulate IGF-I 
expression. Regulation of IGF-I production in a given tissue is therefore complex and 
subject to both systemic and local factors. 
IGF-E is also expressed in a wide variety of tissues during fetal development. 
Postnatally, however, IGF-H expression is extremely limited in rodents, which has 
hindered the development of model systems to examine its regulation. Li humans, 
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unlike rodents, IGF-H production continues into adult life. One clear difference 
between IGF-I and IGF-H is that IGF-H production is independent of GH (Lowe, 
1996). This has led to the rash and generalized conclusion that IGF-H represents the 
fetal growth factor, whereas IGF-I is the corresponding growth factor after birth. 
1.3.3 Expression ofIGFs in the Central Nervous System 
It was found that IGFs in the circulation are not the major source ofIGFs for 
the central nervous system (CNS). IGF-I, IGF-H, IGF-I receptor, and some IGFBPs 
are expressed in many regions of the CNS beginning in utero (D'Ercole et al., 1996). 
The expression pattern of the IGF system proteins during brain growth 
suggests highly regulated and developmentally timed IGF actions on specific neural 
cell populations. IGF-I expression is predominantly in neurons and, in many brain 
regions, peaks in fashion temporally coincident with periods in development when 
neuron progenitor proliferation and^or neuritic outgrowth occurs. For example, in the 
hippocampus, IGF-I expression is high in several proliferative areas in the first 2 
weeks of postnatal life, but peaks later in the dentate gyrus, where neuronal 
proliferation is more prolonged. Purkinje cells are the major cells of IGF-I expression 
in the cerebellum. IGF-I expression in Purkinje cells commences at about the time of 
birth, declines by postnatal day (P) 20, and continues throughout adulthood (Aguado 
et al., 1992; Torres-Aleman et al., 1994). 
Li contrast, IGF-E expression in the brain and head occurs predominately in 
mesenchymal and neural crest derivatives during embryonic life (Stylianopoulou et 
al., 1988). Jn. adult rodent and human brain, the expression of IGF-H appears to be 
confined to the choroid plexus, meninges, and blood vessels (Hynes et aL, 1988; Lee 
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et al., 1993). IGF-E in these sites likely accounts for the abundance of IGF-H in the 
cerebrospinal fluid. 
While expression of IGF-I receptors appears ubiquitous, that of IGFBPs is 
characterized by regional and developmental specificity, and occurs coordinately with 
peaks ofIGF expression. 
1.4 Actions ofIGFs 
The actions of IGFs are now commonly classified into three classes: 
metabolic, mitogenic, and differentiative. It should be noted that generally insulin, 
IGF-I, and IGF-E can substitute each other in promoting all these effects, but with 
differing potencies. Lisulin is more potent in stimulating metabolic effects, whereas 
IGFs are more potent in stimulating growth-promoting effects (Baxter, 1988). 
1.4.1 Insulin-Like Metabolic Effects 
The metabolic activities (mainly anabolic) includes insulin-like actions such as 
simulation of glucose oxidation, glycogen synthesis and amino acid transport, ln some 
cell types (notably adipocytes) these functions may be mediated by cross-reaction of 
the IGFs at insulin receptors, but in other cells, the type I IGF receptor appears to be 
the mediator (Froesch and Zapf, 1985). 
Lisulin-like activity can also be seen in vivo: injection of IGF-I into rats or 
humans elicits a hypoglycaemic response similar to that caused by insulin, and with 
about 6% ofthe potency ofinsulin (Guler et aL, 1987; Zapfet al., 1985). 
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1.4.2 Mitogenic Effects 
The mitogenic activity of the IGFs has been demonstrated in many cell types, 
with increase in DNA, RNA, and protein synthesis, as well as in cell proliferation, 
stimulated by both IGF-I and IGF-E (Baxter, 1986). Jn contrast to other cells, the 
proliferation of lymphocytes was inhibited by IGF-I. Li BALB/c-3T3 fibroblasts, the 
IGFs have been shown to exert their mitogenic activity in synergism with other 
peptides such as platelet-derived growth factor or fibroblast growth factor, which must 
first render the cells "competent" before the IGFs can stimulate DNA synthesis 
(Pledger et aL, 1978; Stiles et aL, 1979 Leof, 1982 #43). Recent research also 
suggested that IGFs and fibroblast growth factors induced cell proliferation in cultured 
utricular epithelial cells (Zheng et al., 1997). 
Gross somatic growth effects can also be seen in vivo, with IGF infusion over 
several days into hypophysectomized rats increasing tibial length, thymidine 
incorporation into cartilage, and body weight (Zapf et al., 1985). Similar results were 
obtained in normal rats (Schoenle et al., 1982) and again in hypophysectomized rats, 
but this time comparing the effects of IGF-I with those of IGF-H (Schoenle et al., 
1985). Li this regard, IGF-H was found to be less potent than IGF-I. 
1.4.3 Effects on Differentiation 
Evidence is accumulating that IGFs can also have distinct effects on the 
differentiation of cells. Rat IGF-H stimulates neurite formation in chick sensory 
neurons (Bothwell, 1983)，while both IGF-I and IGF-H promote myoblast 
differentiation to myotubes (Florini et al., 1991; Stewart et al., 1996; Tollefsen et aL, 
1989). Li the thyroid gland, IGF-I synergises with thyroid stimulating hormone in 
stimulating cell proliferation (Tramontano et al., 1986); comparable effects have also 
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been described in the adrenal cortex (Morera et al., 1986). Thus, it appears that full 
expression of the activity of some pituitary hormones on their target endocrine tissues 
(adrenal and thyroid) may require the concomitant action ofIGF-I (Baxter, 1988). 
1.4.4 IGFs in Reproductive System 
The effects of IGFs on the reproductive systems are well established and a 
variety of differentiation functions are influenced by IGFs (LeRoith et al” 1995). Li 
ovarian granulosa cell, which is primarily involved in the developing ovarian follicle 
and corpus luteum, and which itself synthesizes estrogen and progesterone. IGF-I 
acted synergistically with follicle-stimulating hormone (FSH) to induce receptors for 
luteinising hormone (LH), increase cyclic AMP production, enhanced progesterone 
production, and stimulated steroidogenesis (Adashi et al., 1985; Adashi et al., 1992). 
High levels of IGF-I, IGFBPs, and IGF-I receptor were also found in the 
uterus. Li this organ, estrogen had a marked effect on the expression ofIGF-I (Murphy 
and Friesen, 1988). IGF-I also stimulated biologic functions in the testes. IGF-I 
increased LH binding to Leydig cells and LH-mediated cAMP accumulation. 
Androgen production is also increased by IGF-I (Morera et al., 1987). In summary, 
IGF-I plays an important role in testicular function. 
1.4.5 IGF Actions in the Central Nervous System 
kicreasing evidence strongly supports a role for IGF-I in CNS development. 
IGFs were shown to stimulate the proliferation of neuron progenitors anchor the 
survival of neurons and oligodendrocytes, and in some cultured neurons, to stimulate 
fimction (D'Ercole et al., 1996). Cultured ElO murine neuroepithelial cells appeared to 
be dependent on IGF-I for proliferation and survival (Drago et aL, 1991). Both IGF-I 
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and -H stimulated the proliferation of aggregate cultures of mouse E15-16 neuron and 
glial precursors (Lenoir and Honegger，1983). Jn immortalized hypothalamic neurons, 
IGF-I appears to enhance survival by protecting against the effects of oxidants 
(Sortino and Canonico, 1996). Late gestation rat astrocytes have been shown to 
express IGF-I and -E receptors and to synthesize DNA in response to IGFs (IGF-
I>IGF-n) (Ballotti et al., 1987). Evidence also suggests that IGFs stimulate the 
differentiation of certain neuronal populations. For example, IGFs stimulate 
hypertrophic growth of some neurons. IGF-I stimulates cell hypertrophy, neuritic 
outgrowth, and glutamic acid decarboxylase expression in cultured cortical neurons 
(Aizeman and De Vellis, 1987). 
In vivo studies indicated that IGF-I can affect the development of most, ifnot 
all, brain regions, and suggested to us that the cerebral cortex and cerebellum are 
especially sensitive to IGF-I actions (Torres-Aleman et al., 1994). In vivo growth-
promoting actions of IGF-I is resulted result from its capacity to increase neuron 
number, at least in certain populations, and from its potent stimulation ofmyelination 
OD'Ercole etal., 1996). 
1.5 Transgenic and Knockout Animal Models for IGFs 
To understand the mechanisms of IGF actions in multiple biological processes 
in vivo, trangenic (overexpression of IGFs gain of fimction) and knockout (targeted 
disruption ofIGFs gene loss of function) animals, mainly mice, were studied. 
As expected, transgenic mice overexpressing human IGF-I showed enhanced 
growth (Behringer et al., 1990; D'Ercole, 1993; Mathews et aL, 1988), however 
trangenic mice with over produced IGF-H did not (Van Bull-Offers et al., 1995; Ward 
et al., 1994). A 1.3-fold increase in weight occurred in one transgenic line in which 
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serum IGF-I levels were 1.5 times above controls, although this was manifested as 
elective organomegaly rather than as an increase in skeletal size (Mathews et al., 
1988). Li contrast, overexpression ofhuman IGF-H led to little change in weight or 
length compared with nontransgenic controls, despite up to an eight-fold rise in 
circulating levels fVan Bull-Offers et al., 1995; Ward et aL, 1994). Lack of a positive 
effect on growth was also seen in pituitary-ablated rats administered IGF-H 
(Glasscock et al., 1992). These results, together with observations showing that 
genetic IGF-E deficiency in mice did not alter growth after birth (Dechiara et al., 
1990). 
Knockout mice lacking IGF-I showed markedly diminished postnatal growth 
(Baker et al., 1993; Powell-Braxton et al., 1993), but also had impaired fetal growth 
and development (Liu et aL, 1993; Powell-Braxton et al., 1993). Depending on the 
study, mice heterozygous for a disrupted IGF-I gene were 80-100% the size of wild-
type littermates at birth (Baker et aL, 1993; Powell-Braxton et al., 1993), while 
homozygous mutant animals were � 6 0 % of normal weight and length (Liu et al., 
1993; Powell-Braxton et aL, 1993). 
A decline in growth rate beginning at embryonic day 13.5 was noted in 
homozygotes (Baker et al., 1993). The IGF-I-deficient mice additionally showed 
diminished viability, with perinatal death being attributed to muscle hypoplasia and 
decreased maturation of the lungs (Liu et al., 1993; Powell-Braxton et al., 1993). 
The postulated function of IGF-E as a key fetal growth factor (Daughaday et 
al., 1982; Moses et aL, 1980) was proven when a growth-deficiency phenotype was 
created in mice by targeted disruption of the IGF-H gene (Dechiara et al., 1990). Mice 
lacking IGF-H were �60°/o the size of wild-type littermates at birth (Dechiara et al., 
1990; Liu et al., 1993), and diminished growth was apparent as early as embryonic 
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day 11. As noted above, a normal growth rate was observed after birth, and the 
animals were otherwise viable and fertile (Dechiara et al., 1990). 
Mice lacking both IGF-I and IGF-H, or animals deficient in both IGF-H and 
the IGF-I receptor, had an exacerbated dwarf phenotype and were � 3 0 % of wild-type 
size at term (Liu et al., 1993). These mice died at birth of lung failure and had many 
of the same anatomic defects as were found in IGF-I receptor mutants (Liu et al., 
1993). Taken together, these results demonstrate that expression of each IGF and each 
receptor is required for normal embryonic and fetal growth. 
1.6 Molecular Biology of IGFs 
IGF-I and -H are each the product of a single gene, localized on the long arm 
of chromosome 12 and on the short arm of chromosome 11，respectively in human. 
The IGF-E gene is contiguous by linked with the insulin gene and tyrosine 
hydroxylase gene, the order being 5'-tyrosine hydroxylase-insulin-IGF-n-3 ‘ (Humbel, 
1990). 
1.6.1 Structure of the IGF Genes 
IGF-I Gene Structures 
The genes encoding IGF-I were characterized in human (Rotwein et al., 1986)， 
rat (Shimatsu and Rotwein, 1987)，and chicken (Kajimoto and Rotwein, 1991). The 
mammalian genes consist of six exons arranged as shown in Fig. 1.3. Exon 1 and 2 
encode alternative 5'-untranslated regions O^TRs) and AUG translation initiation 
codons that are in-fi:ame with the open reading frame contained in exon 3 and 4，and 
presumably encode divergent signal peptides. Exon 3 encodes the remainder of the 
signal peptide and part of the B domain of the mature peptide. Exon 4 encodes the 
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Fig. 1.3 Schematic organization of the rat IGF-I gene. Exons (boxes) are to 
scale; introns (lines) are not. Shaded areas represent portions of the prepro-IGF-I open 
reading frame. Horizontal arrows below exons 1 and 2 represent transcription start 
sites. Vertical arrows below exon 6 represent polyadenylation sites. Patterns of 
differential leader exon usage, splicing, and polyadenylation sites usage in different 
IGF-I mRNAs are diagrammed in the lower portion of the figure (Shimatsu and 
Rotwein, 1987). 
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remainder of the B domain, the C, A, and D domains, and the amino-terminus of the 
carboxy-terminal E domain. Exon 5 in the rat and mouse genes encodes a portion ofE 
domain. Jn the human IGF-I gene, the splice junction at the position corresponding to 
the end of exon 5 in the rodent genes has apparently been mutated so that the human 
exon 5 is longer and encodes an extended E domain and the 3'-UTR sequences (Lowe 
et al., 1988). Li all IGF-I genes, exon 6 encodes the carboxy-teminus of the E domain 
andthe3'-UTR. 
Li terms of overall organization, the chicken IGF-I gene is similar to 
mammalian IGF-I genes, except for the apparent absence of exons encoding 
alternative 5 ‘ -UTR/prepeptide coding regions and E domain sequences (corresponding 
to exons 2 and 5) (Kajimoto and Rotwein, 1991). It is conceivable that those exons 
was emerged during mammalian evolution as a mechanism for the diversification of 
signal and E domain sequences to produce multiple forms of IGF-I prepro- and 
prohormones which may have a variety functions. 
IGF-n Gene Structures 
As illustrated by Fig. 1.4，IGF-E gene structure is as complicated as the 
IGF-I gene in terms of overall organization. Exons 1 through 6 encode divergent 
5'UTR sequences. Exons 1，4，5, and 6 are leader exons flanked by independent 
transcription start sites and are, therefore, analogous to exons 1 and 2 of the 
mammalian IGF-I gene. Exons 2 and 3 are present in all exons 1 containing mRNAs. 
Exon 7 encodes the prepeptide and part of the B domain and is thus analagous to exon 
3 of the IGF-I gene. Exon 8 encodes the remainder of the B domain, the C, A, and D 
domains, and the amino terminus of the IGF-H gene E domain, and is thus similar to 
exon 4 of the IGF-I gene. Exon 9 of the IGF-H gene, like exon 6 of the IGF-I gene, 
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Fig. 1.4 Human IGF-E gene structure. Exons (boxes) and introns (lines) are to 
scale. Shaded areas represent portions of the preproIGF-E open reading frame. 
Vertical arrows correspond to promoters, and asterisks to polyadenylation sites. 
Patterns of differential leader exon usage, splicing, and polyadenylation site usage in 
different IGF-H mRNA species and their sizes are shown in the lower portion of the 
figure. 
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encodes the remainder of the E domain and the 3'UTR. Unlike the IGF-I gene, the 
IGF_n genes analyzed to date (human and rat) lack exons that encode alternate 
prepeptide or E domain sequence (Sussenbach, 1989). Exon 1，2，and 3 are absent in 
the rat gene and are inactive in the mouse gene, occurring as "pseudoexons" (Rotwein 
andHall, 1990). 
1.6.2 Expression ofIGF Genes 
IGF-I Gene Expression 
The presence of multiple leader and alternatively spliced exons in the IGF-I 
gene results in a complex pattem of expression illustrated in the lower portion of Fig. 
1.3. Li addition, multiple transcription initiation sites utilized in both leader exons of 
the human (Jansen et al., 1991; Kim et al., 1991), rat and mouse genes (Adamo et al., 
1991; Hall et al., 1992). The majority of transcription in exon 1 is initiated at two sites 
which, in the rat gene, are separated by -100 base pairs (bp). This pattem of 
transcription initiation may be due to the lack of core promoter elements such as 
TATA and CAATT motifs that generally occur � 3 0 and 80 bp, respectively, upstream 
of unique transcription start sites. Transcription in exon 2 is primarily initiated at a 
cluster of sites -60 bp upstream of the 3, end of exon 2，presumably as a result of the 
presence ofTATA and CAATT-like elements at appropriate locations upstream of the 
exons 2 transcription start sites. The combination of multiple transcription start sites 
in exons 1 and 2 and differential splicing in exon 1 produces a collection of IGF-I 
mRNAs which contain divergent 5'-UTRs. As a result, different IGF-I mRNAs are 
translated using different translation initiation codons, one in each exons 1，2 and 3. 
Alternative splicing of exon 5 has been demonstrated in human (Rotwein, 
1986) and rat (Lowe et al., 1988) IGF-I genes and is presumed to occur also in the 
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mouse and ovine genes. The exon 5 sequence, when present, alter the proIGF-I open 
reading frame and the sequence of the E domain. The E domain amino acid sequence 
encoded by the exon 5 containing mRNA lacks the one or two N-linked glycosylation 
sites found in the E domain sequence encoded by exon-5-lacking mRNAs. The two N-
linked glycosylation sites in the pertinent rat E domain sequence were shown to be 
functional in vitro (Bach et al., 1990). 
As illustrated in Fig. 3，exon 6 contains multiple polyadenylation sites. IGF-I 
mRNAs which vary from less than 1 kilobase (kb) to more than 7 kb in length are 
produced through the use of these different processing sites (Lund et al., 1989). The 
high-molecular-weight IGF-I species tends to predominate in extrahepatic tissues. The 
different lengths of3'-UTR can affect the stability ofIGF-I mRNA. 
IGF-n Gene Expression 
As shown in the lower portion of Fig. 1.4, transcription in exons 1，4，5 and 6 
results in IGF-E m RNAs with different 5'UTRs and overall lengths of 6.0，5.3，5.0, 
and 4.8 kb. Exon 5 containing transcripts are polyadenylated at one of two sites in 
exon 9. Use of the more proximal site produces a 2.2-kb IGF-H m RNA. Literestingly, 
endonucleolytic cleavage of the exon 9 sequence results in a presumably 
nonfunctional 1.8-kb mRNA (Meinsma et al., 1991). All of the IGF-H transcripts just 
described (with the exception of the exon 9 derived 1.8-kb species) encode the same 
IGF-n precursor, in contrast to the various IGF-I mRNA species. The use of an 
alternative splice acceptor site at the 5' end of exon 8, however, results in an IGF-H 
mRNA sequence that would encode an additional 4 amino acids in the B domain 
(Jansen et al., 1985). The variant IGF-H peptide presumably encoded by this 
alternatively spliced mRNA has, in fact, been found in serum (Hampton et al., 1989). 
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1.6.3 Regulation of IGF Gene Expression 
The complex organization of these genes provides ample opportunities for 
control of gene expression at multiple levels. It is important to realize that regulation 
at one level can influence regulation at a different level. While such regulatory 
interactions are characteristic of both the IGF-I and IGF-H gene, they are particularly 
evident in the case of IGF-I gene expression. Firstly, the presence of distinct 
transcription initiation sites in the multiple leader exons of mammalian IGF-I genes 
and their differential expression under various conditions suggest that the IGF-I gene 
contain two promoters that regulate transcription initiation at the transcription start 
sites in exons 1 and 2. The choice of transcription start site influences the length and 
the sequence ofthe 5'-UTR (LeRoith et al., 1995). 
Secondly, the translatability of, and the proteins encoded by, IGF-I mRNAs 
with different 5'UTRs may itself be subjected to regulation. In vivo studies suggested 
that IGF-I mRNAs containing these different 5'UTR sequences may be differentially 
translated (Foyt et al., 1992). The different prepeptides encoded by the various IGF-I 
mRNA species may be subjected to differential processing, with possible 
ramifications for IGF-I action (LeRoith and Roberts, 1991) 
Finally, IGF-I biosynthesis might be controlled at the level of mRNA stability, 
as reflected in the apparent differential stability and tissue-specific expression of the 
high-molecular-weight IGF-I mRNA. Thus, one level of control of IGF-I gene 
expression may involve regulation of 3，end processing and poladenylation site 
selection. 
Exon 1, 4, 5, and 6 of the IGF-H gene are flanked by distinct promoters, which 
have been designated P1 through 4. Transcripts initiated at the P2, P3, and P4 
promoters predominate in most embryonic tissues. Hepatic transcripts, which are 
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primarily responsible for circulating IGF-E, are initiated at the P1 promoter after birth 
(dePagter-Holthuisen et al, 1988). Both the P3 and P4 promoters contain TATA 
elements as well as binding sites for transcription factors such as SP1, whereas the P1 
and P2 promoters lack TATA motifs and exhibit disperse transcription initiation 
(Matsuguchi et al., 1990). 
Some evidence were obtained to show IGF-H gene expression being regulated 
at the translational level. Specifically, mRNAs transcribed from the P2 and P4 
promoters, which have shorter 5'UTRs, are enriched in the polysomal RNA fraction 
in comparsion to P3-derived transcripts, which contain longer 5'UTR sequences 
(Matsuguchi et al., 1990). Another possible modulator oflGF-H mRNA translatability 
is the generation of the 1.8_kb fragment of the exon 9 sequence, in that removal of this 
3 'UTR sequence firom the parental mRN"A could affect the stability or translatability 
of the latter. Recent studies reported that the 1.8-kb sequence is itself not translated 
QS[ielsen and Chistiansen, 1992). 
1.7 IGF Receptors 
The biological actions of IGFs are mediated by specific cell membrane 
receptors. The IGF-I receptor and IGF-H receptor can be distinguished by their 
primary structure, relative affinities for their respective ligands, as well as by 
immunological means (Rutanen and Pekonen, 1990). 
1.7.1 IGF-I Receptor 
The IGF-I receptor (Fig. 1.5), like most growth factor receptors, possess 
tyrosine kinase activity and is responsible for signaling the mitogenic and possibly all 
of the growth-promoting effects of IGF-I and IGF-H. It is a heterotetramer composed 
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Fig. 1.5 IGF-I receptor (Left) and IGF-n/mannose-6-phosphate receptor (Right). 
The insulin receptor also is a heterotetramer with a structure very similar to that of the 
IGF-I receptor (D'Ercole, 1996). 
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of paired, disulflde-linked a and P subunits. The a subunits span the cell membrane 
and include a tyrosine kinase and a carboxy terminus containing three tyrosine 
residues that are important in signaling. The entire receptor is the product of a single 
gene and shares structural homology with the insulin receptor (D'Ercole, 1996). 
1.7.2 IGF-n Receptor 
The IGF-E receptor (Fig. 1.5) is identical to mannose-6-phosphate receptor. It 
translocates proteins containing mannose-6-phosphate moieties and IGF-H to 
lysosomes for degradation. There is little evidence to a support a signaling function 
for this receptor, although such as function has not been excluded. Thus, IGF-H 
receptor do not seem to mediate the growth-promoting actions of IGFs (D'Ercole, 
1996). 
1.8 IGFBPs 
Six distinct IGFBPs have been identified so far. They are numbered IGFBP-1 
to 6 in the order in which their primary sequences were determined. One of the best 
studied is IGFBP-3 which appears to serve as an intravascular storage reservoir for 
IGFs. Serum levels ofIGFBP-3 are responsive to GH. Lti states of GH depletion, IGF-I 
binds to IGFBP-3 with the sebsequent association of an acid-labile subunit to form a 
ternary complex (Lowe, 1996). About 75% of the IGF-I and IGF-H in the circulation 
is carried in these complexes. Free in plasma, the half-life of IGF-I is about 10 
minutes, but in temary complexes it is 12 to 15 hours. The temary complex cannot 
cross the endothelial barrier and is thus confined to the circulation (Rutanen and 
Pekonen, 1990). 
26 
IGFBP-1, 2, and 4 are also present in the circulation. These binding proteins 
are capable of crossing the vascular endothelium, so IGFs bound to them instead of 
IGFBP-3 could be transported from the plasma to target cells. Li case ofIGFBP-2 and 
4，subsequent proteolytic cleavage drastically reduces binding affinity, allowing IGFs 
to bind to the IGF receptors (Bach and Rechler, 1995). 
A second role for IGFBPs is to both inhibit and augment IGF action. In some 
cases, depending on the experimental conditions, the same binding protein can either 
promote or inhibit IGF activity. When added in large concentrations to cell cultures, 
IGFBP-1, 2, 3 and 4 inhibit IGFs, presumably by binding to them and limiting their 
access to the IGF-I receptor, whereas IGFBP-1, 3, and 5 also promote IGF actions 
(also see Table 1.1) 0-owe, 1996). 
Table 1.1 Characteristics of IGFBPs (Adapted from Lowe, 1996) 
IGFBP-1 Found in high concentrations in amniotic fluid 
Secreted by hepatocytes, decidua 
Regulated by insulin, cAMP, and other factors 
IGFBP-2 Found in serum, CSF, seminal plasma 
Secreted by many cell types 
Expression higher in fetal than in adult tissues 
IGFBP-3 Major binding protein in serum 
Secreted by hepatocytes and other cells 
Serum levels are GH-dependent 
IGFBP-4 mRNA present in many tissues, greatest abundance in liver 
L:ihibits IGF action in many cell types 
IGFBP-5 mRNA is most abundant in kidney but present in many tissues 
Serum levels are low 
Associates with the extracellular matrix 
IGFBP-6 Present in serum and CSF 
mRNA is abundant in many tissues 
Significantly higher af&iity for IGF-H than for IGF-I 
27 
1.9 Teleost IGFs 
Li the past, most of the studies on IGFs have been focused on mammals. Until 
recently, more research work has been focused on other non-mammalian species, 
notably fish. 
1.9.1 The GH-IGF-Axis in Teleost 
The basic mechanism of GH-IGF axis is also shown to be operative but in a 
different manner in teleost. Jn addition to IGF-I, IGF-E also show GH-dependence 
(Shamblott et al., 1995). Both IGF-I and GH were found to be related to somatic 
growth (Gray and Kelly, 1991; McCoraiick et al., 1992; Skyrud et aL, 1989). 
RNase protection assay was used to study the effect of bovine GH on the 
levels of IGF-I and IGF-H mRNA in juvenile rainbow trout {Oncorhynchus mykiss) 
(Shamblott et al., 1995). A single i.p. injection ofbovine GH at a dose of lOug/g body 
weight resulted in significant increase in IGF-I and IGF-H mRNA levels in liver when 
compared with control. Li addition to IGF-I, the GH-dependent appearance of IGF-H 
mRNA in the liver suggests important roles for this peptide hormone exclusive of 
IGF-I. 
Radioimmunoassay was used to study the effect of salmon GH on plasma level 
of immunoreactive IGF-I in rainbow trout (Moriyama, 1995). Following oral or i.p. 
administration of sahnon GH at a dose of 0.1 or 1 .Oug/g body weight, the plasma IGF-
I levels were significantly elevated. The results indicate that plasma IGF-I in salmonid 
fish is under GH control and that oral administration of the hormone is followed by 
longer-lasting effects than those achieved by i.p. injection. 
Coho salmon {Oncorhynchus kisutch) received implants of osmotic 
minipumps containing recombinant bovine IGF-I increased both linear growth and 
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growth rate in weight. However, high doses of IGF-I resulted in hypoglycemia and 
death (McCormick et al., 1992). Also, GH and IGF-I act in a synergistic mode in 
stimulating sulfate uptake by branchial cartilage in vitro in common carp {Cyprinus 
carpid). 
Like mammals, nutritional status is also an important factor in GH and IGF-I 
regulation in teleost (Duan and Hirano, 1992; Duan and Plisetskaya, 1993; Perez-
Sanchez et al., 1995). Jn eel {Anguilla japonica), the hepatic sulfation activity was 
significantly decreased by hypophysectomy or fasting for 14 days. This experiment 
suggested that the sulfation activity was regulated by pituitary function and nutritional 
status (Duan and Hirano, 1992). Li sahnon, food deprivation primarily reduces IGF-I 
mRNA expression in the liver which results, most probably, in a decline in systemic 
IGF-I levels and consequently leads to the retarded growth of sahnon (Duan and 
Plisetskaya, 1993). 
All these results showed that the growth-promoting actions and the basic 
mechanism of GH-IGF axis in mammal are generally true in fish. 
1.9.2 Osmoregulation and Other Biological Actions of IGF in Teleost 
Li 1993，Sakamoto and Hirano studied the importance of GH-IGF-I axis in 
osmoregulation in specific organs in fish. The IGF-I mRNA in liver, gill and kidney of 
rainbow trout were measured by Northern analysis. After GH injection, IGF-I mRNA 
increased signficantly in these tissues. Transferring trout from fresh water to 80% sea 
water showed increase of their circulating GH after 1 day. IGF-I mRNA was altered 
significantly in the liver but were found to be induced in gill and kidney after 1 day 
and 8 days respectively. These observations suggested that the IGF-I gene was 
expressed differently among these organs during sea water adaptation. Therefore, GH 
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may stimulate hypoosmoregulation by inducing local IGF-I expression in 
osmoregulatory organs such as kidney and gill (Sakamoto and Hirano, 1993). 
IGFs are also involved in the reproductive physiology in teleost. Li 
spermatogenesis of rainbow trout, IGFs stimulate DNA synthesis of male germ cells 
by interacting directly with these cells through IGF-I receptor (Loir and Le Gac, 
1994). In red seabream (Pagrus major), IGF-I and -H induced final maturation of 
oocytes in vitro (Kagawa et al., 1994). 
It was also shown that IGFs play a role in regulating production of new 
neurons in the teleost retina (Mack et aL, 1995) and the role ofIGF-I in the regulation 
of brain growth, development and, possibly, some neurotrophic and neuromodulatory 
mechanism (Leibush et al., 1996). 
1.9.3 Molecular Biology of IGFs in Teleost 
The presence ofboth IGF-I and IGF-E in teleost suggested that the divergence 
of IGFs occurred early in vertebrate evolution (Duguay et al., 1996; Shamblott and 
Chen, 1992). 
A portion of the IGF-I cDNA (including the B, C, and A domains, -120bp) 
was amlified by RT-PCR from juvenile rainbow trout and was used as a probe to 
isolate trout IGF cDNAs. After cloning and DNA sequencing, 4 different forms of 
IGF-I mRNA (with different lengths in the E domain) and 1 form of IGF-H mRNA 
were identified (Shamblott and Chen, 1993). In the past, it was believed that IGF-H 
did not exist in fish, IGF-I and H were diverged only after mammalian radiation. This 
was the first time an IGF-H mRNA was identified in teleost (Shamblott and Chen, 
1992). 
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Until now, only two nonalleic IGF-I genes (IGF-I.1 and IGF-L2) were isolated 
from chum sahnon (Oncorhynchus tshawytscha) (Kavsan et al” 1994; Kavsan et al., 
1993). The IGF-L2 gene differ from IGF-I. 1 gene in the E peptide coding portion, in 
that it lacks one codon present in the IGF-L1 gene and contains two potential splice 
donor sites at the 3’ end of exon 3 rather than one site in IGF-L1. It was speculated 
that the expression of these two IGF-I genes could give rise to six different forms of 
IGF-I mRNA in chum salmon. 
For non-sahnonids, common carp was found to express only one form ofIGF-I 
cDNA (Liang et al., 1996). RT-PCR showed that the liver of both sexes is the major 
site ofIGF-I. expression 
1.9.4 IGFBPs and IGF Receptors in Teleost 
Westem blot analysis using ^^^I-labeled human IGF-I identified at least three 
major forms of IGFBPs in the plasma of 4 different teleost species (coho salmon 
(Oncorhynchus kisutch), striped bass {Morone saxatilis), tilapia {Oreochromis 
mossambicus) and longjawed mudsucker {Gillichthys mirabilis) . One form was about 
40-50kDa, possibly GH dependent and seemed to be the teleost version of mammalian 
IGFBP-3. The second and third forms had sizes of 29 kDa and 31 kDa. They might be 
the teleost version of mammalian IGFBP-1 and -2 (Kelly et al., 1992). 
Li another independent study using Westem blot analysis, the binding of 125j_ 
labeled human IGF-I to trout serum gave positive bands of variable size. The 41.5 kDa 
and 38.5 kDa bands might correspond to IGF binding protein 3，whereas the 34 kDa, 
30 kDa, and 24 kDa bands might correspond to IGF binding protein- 2，-1 and -4 fNiu 
andLe Bail, 1993). 
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Competitive binding studies and affinity labeling of brain membranes from 3 
primitive vertebrates sea scorpion {Cottus scorpius), ray (Raja clavata) and Atlantic 
hagfish {Myxine glutinosa) identified an IGF-I receptor by the size of its a subunit and 
its binding specificity to both IGF-I and IGF-E peptides ^Darkenberg et aL, 1993). 
1.10 Rationale and Aim of the Present Study 
Li the past, it was generally believed that IGF-H evolved after the divergence 
of mammals from other chorates (Shamblott and Chen, 1992). Until recently, IGFs 
have been identified in a limited number of nonmammalian species. Multiple forms of 
IGF-I and one form of IGF-E cDNA sequence were identified in rainbow trout 
(Shamblott and Chen, 1993). Two IGF-I genes were cloned in the genome of chum 
salmon (Kavsan et al., 1994; Kavsan et al., 1993). 
Li common carp, however, only one subtype of IGF-I and no IGF-H was found 
so far fLiang et al., 1996). On the other hand, genomic Southern analysis performed 
on common carp demonstrated that there could be more than one IGF gene in the 
genome of common carp (unpublished work). The solution of this apparent dichotomy 
is dependent upon the isolation and cloning of IGF gene(s) from common carp. The 
aim of this study is to screen a common carp genomic library to see if we could 
identify the IGF gene(s) in the genome of common carp. Genomic Southern analysis 
was also used to detect the IGF-H gene using a rtIGF-H cDNA probe. 
The IGF-I promoter region of fish exhibit many similarities revealed that the 
regulation of IGF-I expression is conserved among the teleost. For example, the 
promoter region of IGF-I gene in several fish species have been cloned and 
characterized (Funkenstein et aL, 1996; Kavsan et al., 1993; Koval et al., 1994; Kulik 
et al., 1995). To see whether the promoter is also conserved in common carp and 
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study the promoter activity of the common carp IGF-I gene, we must first clone the 
promoter of common carp. Li this study, we use PCR to amplify the upstream 5，-
flanking region of the common carp genomic DNA. 
Li fish, the basic mechanism of GH-IGF axis is shown to be operative but in a 
different manner. Li addition to IGF-I, IGF-H also show GH-dependence (Shamblott 
et al., 1995). It was suggested that both IGF-I and IGF-E may have growth effects in 
teleost (Duguay et aL, 1996; Shamblott and Chen, 1992) Both IGF-I and GH were 
found to be related to somatic growth (Gray and Kelly, 1991; McCormick et al., 1992; 
Skyrud et aL, 1989). To prove the GH-IGF-I axis work also in the common carp, IGF-
I gene expression study was carried out using Northern blot analysis and RT-PCR. 
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CHAPTER 2 SEARCH OF IGF-I PROMOTER BY GENOMIC DNA 
POLYMERASE CHAIN REACTION 
2.1 Introduction 
The 5，regions of the human and rat IGF-I genes exhibit many similarities. 
Both genes contain two leader exons (1 and 2) that encode different 5'-UTR 
sequences (Rotwein et al., 1986; Shimatsu and Rotwein, 1987) and that contain 
multiple transcription start sites (Jansen et al., 1991). All transcript contain upstream, 
in frame translation initiation codons and therfore may encode different signal 
peptides. The nucleotide sequences ofhuman exons 1 and 2 are highly homologous to 
the corresponding regions of the rat IGF-I gene. No concensus TATA box or AT-rich 
regions are present within the first 50 nucleotides upstream of any of the exon 1 
transcription start sites determined, nor are these regions particularly GC-rich, 
suggesting that the exon 1 promoter regions belong to the class of TATA-less non-
GC-rich promoters. Potential TATA- and CCAAT-like elements are present upstream 
of the major exon 2 start site in rat (Adamo et aL, 1991), but the role of these in exon 
2 transcription has yet to determined. 
Several IGF-I promoter regions were cloned and characterized in fish species 
(Kavsan et al., 1993; Koval et aL, 1994; Kulik et al., 1995; Funkenstein et al., 1996). 
The sequences were found to be similar among the teleosts and indicated that the 
regulation of expression is identical in fish. Jn common carp, an IGF-I Ea2 cDNA was 
isolated (Liang et al., 1996). To study and see whether the IGF-I promoter region of 
common carp is similar to other fish species, we cloned the 5'-flanking region by PCR 
according to the known sequence of the common carp IGF-I Ea2 cDNA. 
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2.2 Materials 





lOmgy'ml Proteinase K CBoehringer Mannheim) 
10M Ammonium acetate (Section 2.3.1) 
770g ammonium acetate 
Add ddH2O to 1 liter, sterilize by filtration. 
50X Tris acetate (TAE) (Section 2.3.4) 
242g Tris base 
57.1 ml glacial acetic acid 
100 ml0.5MEDTA, pH8.0 
Add ddH2O to 1 liter. 
6X Loading buffer for agarose gel electrophoresis (Section 2.3.4) 
0.25% bromophenol blue 
0.25% xylene cyanol FF 
40% (w/v) sucrose in water 
Gel Solubilizer (Section 2.3.5) 
6MNaI 
50mM Tris-Cl，pH 8.0 
0.05% Na2SO3 
lOmMEDTA 
Wash Buffer (Section 2.3.5) 




10X Ligation Buffer (section 2.3.6) 
60 mM Tris-HCl, pH 7.5 
60 m M MgCl2 
50mMNaCl 
1 mg/ml bovine serum albumin 
70 mM p-mercaptoethanol 
lmMATP 
20 mM dithiothreitol 
10 mM spermidine 
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LB OLuria-Bertani) medium (Section 2.3.7) 
Bacto-tryptone 10 g 
Bacto-yeast extract 5 g 
NaCl 10g 
Add ddH2O to 1 liter, sterilize the buffer by autoclaving for 20 min at 151b/sq. in. 
liquid cycle. 
LB plate (Section 2.3.7) 
Composition the same as LB medium except with 1.5% agar. 
Isopropylthio-P-D-galactoside OOPTG) (Section 2.3.7) 
2g n>TG 
Add H2O to 10ml 
Sterilize the solution by filtration through a 0.22 fim filter. 
Xgal (5-bromo-4-chloro-3-indolyl-P-D galactoside) (Section 2.3.7) 
200 mg 5-bromo-4-chloro-3-indolyl-P-D galactoside (Xgal) 
Dissolve in 10ml dimethylformamide and store in a dark bottle. 
Solution I (Section 2.3.8) 
50mMTris-Cl, pH7.5 
lOmMEDTA 
lOO i^gAnl RNase A 
Sterilize the buffer by autoclaving for 20 min at 151b/sq. in. liquid cycle. 
Solution n (Section 2.3.8) 
0.2NNaOH 
1% SDS 
Solution m (Section 2.3.8) 
3M potassium acetate, pH 4.8 
A mix-short (Section 2.3.11) 
840 |iM each dCTP, dGTP and dTTP 
93.5 ^M dATP 
14 i^M ddATP 
40mMTris-Cl, pH7.6 
50mMNaCl 
T mix-short (Section 2.3.11) 
840 MM each dCTP, dGTP and dATP 
93.5 i^M dTTP 
14^iM ddTTP 
40 mM Tris-Cl, pH 7.6 
50mMNaCl 
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G mix-short (Section 2.3.11) 
840 MM each dCTP, dATP and dTTP 
93.5 |iiM dGTP 
14 i^M ddGTP 
40 mM Tris-Cl, pH 7.6 
50mMNaCl 
C mix-short (Section 2.3.11) 
840 [M each dATP, dGTP and dTTP 
93.5 ^MdCTP 
17 i^M ddCTP 
40mMTris-Cl, pH7.6 
50mMNaCl 
Enzyme dilution buffer (Section 2.3.11) 
20mM Tris-Cl, pH 7.5 
5 mM dithiothreitol (DTT) 
100^g bovine serum albuminAnl 
5% glycerol 
Annealing Buffer (Section 2.3.11) 
1 M Tris-Cl, pH 7.6 
100mM MgCl2 
160mMDTT 
Labeling Mix-dATP (Section 2.3.11) 
1.375^M each dCTP,dGTP and dTTP 
333.5 mMNaCl 
Stop solution (Section 2.3.11) 
0.3 % bromophenol blue 
0.3% xylene cyanol FF 
10 mM EDTA, pH 7.5 
97.5% deionized formamide 
5X Tris-borate (TBE) (Section 2.3.11) 
54g Tris base 
27.5g boric acid 
20ml 0.5M EDTA, pH8.0 
Add ddH2O to 1 liter. 
20% Acrylalmide for sequencing gel (Section 2.3.11) 
acrylamide 96.5g 
methylene-bis-acrylamide 3.3 5 g 
ultra-pure urea 233.5 g 
5X TBE 100ml 
H2O to 500ml 
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Urea mix for sequencing gel (Section 2.3.11) 
urea 233.5g 
5XTBE 100ml 
H2O to 500ml 
38 
2.3 Methods 
2.3.1 Preparation of Genomic DNA from Carp Testis 
Genomic DNA of common carp was prepared according to the method 
described by Scott et al. (1985). Li brief, testis tissue (0.5 g) was dropped into a 
mortar which has been filled with liquid nitrogen. The tissue was ground to powder 
and then 40 ml of grinding buffer (Section 2.2) was added slowly. The mixture was 
ground until homogeneous and then poured into a 150 ml Ehrlenmeyer flask. It was 
then incubated at 65^C with shaking for 3 hr. Four mg Proteinase K (Boehringer 
Mannheim) was further added and the mixture was incubated at 65®C with shaking 
ovemight. The mixture was cooled and transferred to a centrifuge tube. An equal 
volume of phenol equilibrated with 0.5 M Tris-Cl (pH 8.0) was added and the tube 
was placed on a roller apparatus for 1 hr. The aqueous and organic phase was 
separated by centrifUgation at 5,000g for 15 min. The aqueous phase was transferred 
to a clean tube using wide bore pipette tip and the phenol extraction was repeated 
twice. After phenol extraction, the aqueous phase was transferred to a fi:esh centrifuge 
tube. Ammonium acetate (10 M，0.2 volume) (Section 2.2) and 2 volume of ethanol 
was added and mixed thoroughly. The DNA thread formed immediately was removed 
by a heat-bended Pasteur pipette. The DNA was washed by 70% ethanol and then 
collected by centrifugation. The DNA pellet was then dissolved in an appropriate 
amount of TE ^>H 8.0). The absorbance of the DNA at 260 nm and 280nm was 
measured. The ratio of A26O to A28O should be greater than 1.75. A lower ratio is an 
indication that significant amounts of protein remain in the preparation. 
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2.3.2 Restriction Enzyme Digestion of Genomic DNA 
Genomic DNA samples were digested by restriction enzymes. About 1 ^g of 
genomic PNA was digested with excess amount of restriction enzymes. Eco RI, Hin6. 
ni and Xba I were used to digest samples of the genomic DNA in 50 ^1 of the 
corresponding buffer. The reaction mixtures were incubated at 2>TC for 4 hr. The 
digested DNA samples were precipitated and dissolved in 10 ^1 sterilized water. 
2.3.3 Polymerase Chain Reaction 
2.3.3.1 Ligation ofthe Cassette to Digested Genomic DNA 
Five ^1 of the digested DNA samples were ligated to the 50 ng Cassette with 
restriction site corresponding to Eco RI, Hind HI and Xba I in 15 ^1 of recommended 
ligation solution provided by the PCR in vitro Cloning Kit (Takara, Japan). The 
reaction mixture were incubated at 16°C for 30 min. The ligated DNA samples were 
precipitated and dissolved in 5 p,l sterilized water. 
2.3.3.2 Amplification by PCR 
One ^1 of the ligated DNA samples were used for the first PCR and 1 ^ 1 of the 
first PCR reaction mixture was used for the second PCR, using a PTC-100 thermal 
cycler (MJ Research, USA): 94�C，1 min; 55�C，2 min; 72�C，3 min; for 25 cycles. Jn 
each PCR reaction, 2.5 units of Takara Taq polymerase were used and 20 pmole of 
each primer were used in a reaction of 100 |il. IGF-I specific primers (S1 and S2) were 
designed from the coding region of common carp cDNA signal peptide ^.iang et cd., 
1996). The position of the primers are shown in Fig. 2.1. The Cassette Primers were 
obtained from the kit (Takara, Japan). 
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5' untranslated region  
TCCAAATCCGTCTCCTGTTCGCTAAATCTCACTTCTCCACAACGAGCCTGCGCAATGGAACAAAGTC 67 
Primer S3 




Primer S2 4  \  
TTTTTGCTGGGCTTTTGCTGGAGACCCAAGGGATG TCT AGC GGA CAT TTC TTC CAG GGG CAT 200 
lePheAlaGlyLeuLeuLeuGluThrGlnGlyMet Ser Ser Gly His Phe Phe Gln Gly His 27 
Rsa I  
TGG TGT GAT GTC TTT AAG TGT ACC ATG CGC TGT CTC TCG TGC ACC CAC ACC CTC 254 
Trp Cys Asp Val Phe Lys Cys Thr Met Arg Cys Leu Ser Cys Thr His Thr Leu 45 
B domain 
TCA CTG GTG CTG TGC GTC CTC GCG TTG ACT CCC GCG ACA CTG GA6 GCG GGG CCG 3 08 
Ser Leu Val Leu Cys Val Leu Ala Leu Thr Pro Ala Thr Leu Glu Ala Gly Pro 63 
Pst I  
6AG ACG CTG TGC GGG GCG GAG CTT GTA 6AC ACG CTG CAG TTT GTG TGT GGA GAC 362 
Glu Thr Leu Cys Gly Ala Glu Leu Val Asp Thr Leu Gln Phe Val Cys Gly Asp 81 
I I C domain  
AG6 GGC TTT TAT TTC AGC AAA CCA ACA GGA TAT GGG CCT AGT TCA A6A CGG TCA 416 
Arg Gly Phe Tyr Phe Ser Lys Pro Thr Gly Tyr Gly Pro Ser Ser Arg Arg Ser 99 
A domain  
CAC AAC CGT GGC ATT GTG GAT 6AA TGC TGC TTT CAG AGC TGT GAG CTG AGG CGC 470 
His Asn Arg Gly Ile Val Asp Glu Cys Cys Phe Gln Ser Cys Glu Leu Arg Arg 117 
Xho I I |D domain | |E domain.l^sa I. 
CTC GAG ATG TAT TGT GCA CCC GTA AAG CCC GGC AAA ACT CCA CGA TCC QTA CGA 524 
Leu Glu Met Tyr Cys Ala Pro Val Lys Pro Gly Lys Thr Pro Arg Ser Val Arg 135 
GCG CAA CGG CAT ACA GAC AGC CCA AGG ACA GCA AAG AAA CCT TTA CCT GGA CAA 578 
Ala Gln Arg His Thr Asp Ser Pro Arg Thr Ala Lys Lys Pro Leu Pro Gly Gln 153 
Xho I  
AGC CAC TCT TCC TAT AAG GAG GTT CAT CAG AAG AAC TCG AGC AGA GGA AAC ACA 632 
Ser His Ser Ser Tyr Lys Glu Val His Gln Lys Asn Ser Ser Arg Gly Asn Thr 171 
3'untranslated region  
GGG GGA AGA AAC TAT CGC ATT TAGAGGACAGTAAGGCGAATGGCTGAGAGAGACAAGTGAAACT 696 




Fig. 2.1 Nucleotide sequence and the predicted amino acid sequence of the 
common carp IGF-I cDNA clone (Liang et al., 1996). Labeled arrows above the 
sequence represent the positions and 5' to 3，direction of the primers used in Takara 
PCR and DNA sequencing. 
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The nucleotide sequences of primer sets for PCR are: 
First round ofPCR, 
IGF-I specific primer (S 1): 5'CCCCTGGAAGAAATGTCCGCTAGA3', and 
Cassette Primer (C1): 5‘GTACATATTGTCGTTAGAACGCG3‘. 
Second round ofPCR, 
IGF-I specific primer (S2): 5'AGACATCCCTTGGGTCTCCAGCAA3‘, and 
Cassette Primer (C1): 5'TAATACGACTCACTATAGGGAGA3‘. 
2.3.4 Agarose Gel Electrophoresis 
Ten ^1 of the final PCR reaction mixture and 6X gel-loading buffer (Section 
2.2) was added to a final concentration of IX. The gel was prepared with 1.2% (w/v) 
agarose dissolved in IX TAE buffer (Section 2.2). Electrophoresis was performed at a 
constant voltage of 100V in a gel tank with IX TAE. After electrophoresis, the gel 
was stained in ethidium bromide ^EtBr) solution (lOmgy'ml) and visualized on a 
Fotodyne UV transilluminator at 300nm. 
2.3.5 Gene Clean Using Sephaglas™ BandPrep Kit (Pharmacia) 
The agarose gel containing the desired DNA band was excised, weighed and 
put into a 1.5 ml microfuge tube where 250 i^l of Gel Solubilizer (Section 2.2) was 
added, and the mixture was incubated at 60^C for 5-10 min until the agarose slice 
dissolved. Five p,l of Sephaglas BP was added to bind the DNA, the tube was vortexed 
gently and incubated for 5 min at room temperature. The tube was centrifuged for 10 
sec at full speed in a microcentrifuge and the supernatant was carefully removed. The 
Sephaglas pellet was then washed with 40 i^l of Wash Buffer (Section 2.2). The tube 
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was centrifiiged at full speed for 10 sec and the supernatant was carefully removed. 
This washing step was repeated twice. The Sephaglas pellet was allowed to air dry for 
10 min to remove any residual ethanol. Finally, the DNA was eluted in 20 ^1 
preheated water (55-650Q. 
2.3.6 Cloning of PCR Products 
Fifteen i^l of the PCR product (from Section 2.3.4) isolated was added to 50 ng 
of the pCR® 2.1 vector and mixed with 4 Weiss units of T4 DNA Ligase was used in 
20 |il of the recommended ligation buffer (Section 2.2) provided by the Original TA 
Cloning® Kit (Livitrogen). The ligation mixture was incubated overnight at 14°C. 
2.3.7 Transformation of Competent Cell (Heat Shock Method) 
DH5a competent cells were used the for transformation with the plasmid 
vector. The competent cells which were stored in -70^C was thawed at room 
temperature until the cell suspension is just thawed. Then the cells were placed on ice. 
Twenty p,l of the ligation mixture (Section 2.3.6) were added to lOO i^l competent cells 
and mixed by swirling. The tube was placed on ice for 30-60 min. The cells were heat 
shocked in 42^C for 90 sec and then quick chilled on ice for a few min. Nine hundred 
^1 of LB medium (Section 2.2) was added to the cells and incubated at 37^C with 
moderate agitation for 60 min to allow the bacteria to recover and to express the 
antibiotic resistance gene encoded by the plasmid. One hundred ^1 of the transformed 
competent cells with 20 ^1 of 100mM EPTG (Section 2.2) and 50 i^l of2%(w/v) X-gal 
(Section 2.2) were spreaded onto a LB agar plate (Section 2.2) containing Ampicillin 
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(0.1 mg/ml). The plate was then incubated at 37^C overnight (Sambrook et al., 1989). 
The white colonies were picked for plasmid minipreparation. 
V 
2.3.8 Small Scale Alkali Preparation of Plasmid DNA 
To confirm that the colonies (from Section 2.3.7) obtained were positives, the 
plasmid DNA of these colonies were prepared by alkaline lysis (Sambrook et al., 
1989). A single colony of bacteria was transferred into 2ml ofLB medium in snap-
capped 15 ml culture tube. The culture was incubated at 37^C ovemight with vigorous 
(250 rpm) shaking. One and a half ml was transferred to a microfuge tube and 
centrifuged at 12,000 g for 30 sec at 4^C. The remainder of the culture was stored at 
4^C. The supernatant was discarded and the pellet resuspended in 100 ^1 of ice-cold 
Solution I (Section 2.2) by vigorous vortexing. Two hundred ml of freshly prepared 
Solution n (Section 2.2) were added and mixed by inverting the tubes several times. 
One hundred and fifty p,l of ice-cold Solution DI (Section 2.2) were then added and 
mixed by inverting the tube several times. The tube was kept on ice for 5 min and then 
centrifuged at 12,000g for 5min at 4®C, the supematant was then transferred to a fresh 
tube. The plasmid DNA was precipitated by addition of 2 volumes of ethanol (95%) at 
room temperature for 10 min. It was then centrifuged at 12,000g for 5 min at 4®C. The 
supernatant was discarded and the pellet washed by 1 ml 70 % ethanol at 4^C. The 
ethanol was removed and the pellet was allowed to air dry for about 10 min under 
vacuum. Finally, the DNA pellet was dissolved in 50 pi ddH2O and stored at -20^C. 
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2.3.9 Restriction Enzyme Digestion to Release the Insert 
The sizes of the insert from positive clones (from Section 2.3.8) were checked 
after restriction enzyme digestion. Five i^l of plasmid DNA were digested by 10 units 
of Eco RI (cloning site) in 20 ^1 corresponding buffer. The reaction mixture was 
incubated at 2>TC for 4 hr. Agarose gel electrophoresis was performed using 10 |al of 
the digested plasmid on a 1.2% (w/v) agarose gel (Section 2.3.4). 
2.3.10 Large Scale Plasmid Preparation of the Positive Clone Using 
Large scale plasmid preparation was carried using the Wizard Maxiprep Kit 
(Promega). One hundred to five hundred ml ovemight culture of E. coli were prepared 
and the bacteria was pelleted by centrifugation at 14,000g for 10 min at 4^C. The 
bacterial pellet was then completely resuspended in 15 ml of Cell Resuspension 
Solution (Solution I，Section 2.2). Fifteen ml of Cell Lysis Solution (Solution E, 
Section 2.2) were added and mixed gently, but thoroughly, by stirring or inverting 
until the solution becomes clear and viscous. Fifteen ml of Neutralization Solution 
(Solution DI, Section 2,2) were added and mixed by inverting the centrifuge bottle 
several times. The mixture was filtered through filter paper (Whatman #1，GFA) in to 
a centrifuge bottle. Isopropanol (0.6 volume) was added and mixed by inversion. The 
mixture was stored at -20^C for at least 1 hr and then centrifuged at 14,000g for 15 
min at 4^C to collect the plasmid. The supernatant was discarded and the DNA pellet 
was resuspended in 2 ml TE buffer. Ten ml of Wizard Maxipreps DNA Purification 
Resin were added to the DNA solution and mixed by swirling. For each maxiprep, one 
Wizard Maxicolumn was used. The Maxicolumn tip was inserted into the vacuum 
source. A vacuum was applied to pull the Resin/DNA mix into the Maxicolumn. The 
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ResinyDNA mix was washed by 12.5 ml Column Wash solution (Section 2.2) for two 
times and a vacuum was applied to draw the Wash solution through the Maxicolumn. 
To rinse the Resin, 5ml of 80 % ethanol were added to the Maxicolumn and a vacuum 
was applied to draw the ethanol through the Maxicolumn. The Resin was further by 
centrifugation at 2,500 rpm for 5 min. 
One and a half ml preheated (65-70OC) ddH2O (1.5 ml) were added to the 
Maxicolumn. After 1 min, the DNA was eluted by centrifuging the 
Maxicolumny^eservoir at 2,500 rpm for 5 min. The plasmid DNA may then be stored 
at 40C or -20OC. 
2.3.11 DNA Sequencing of the Positive Clone Using the T7 DNA 
Polymerase Sequencing Kit (Pharmacia) 
The concentration of the template was adjusted so that 32^1 of ddH2O 
contained 1.5 to 2 [xg DNA. The double-stranded template was denatured by mixing 
32|il clone and 8|il 2M NaOH in a microcentrifuge tube. The tube was then incubated 
at room temperature for 10 min. Seven ^1 of 3M sodium acetate (pH 4.8) and 4^1 of 
distilled water was added and mixed. One hundred and twenty ^1 of 100% ethanol 
were added to the mixture. The content was mixed by inverting the tube several times, 
and placed on dry ice for 15 min. The DNA was then centrifuged down at full speed 
for 15 min. The supernatant was discarded and the pellet was washed with ice-cold 
70% ethanol followed by recentrifugation for 10 min at full speed. The supernatant 
was discarded. The DNA pellet was dried under vacuum, and redissolved in 10 ^1 of 
ddH2O. 
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The concentration of primer was adjusted to 2.5-5 juM. The primer and the 
Annealing Buffer (Section 2.2) were added to the resuspended template, as indicated 
below: 
Template DNA _ 
Primer 2 i^l 
Annealing Buffer 2|id 
Total volume 14jid 
The tube was vortexed gently, then centrifuged briefly and incubated at 65^C 
for 5 min. The tube was transferred to a 37^C water bath and incubated for 10 min. 
The tube was then stored at room temperature for at least 5 min, and then centrifuged 
briefly. Two and a half ^1 respectively of A mix-short, C mix-short, G mix-short and 
T mix-short (Section 2.2) were transferred into separate microcentrifuge tubes. 
To the tube containing the annealed template and primer, 3^1 labeling mix 
(Section 2.2), lp, labeled dNTP and 2^1 of diluted T7 DNA Polymerase (4 units) were 
added. The components were mixed by gentle pipetting, and incubated at room 
temperature for 5 min. While this incubation was in progress, the four sequencing 
mixes were warmed by placing the microcentrifuge tubes at 37^C for at least 1 min. 
After the 5-min incubation of the labeling reaction, 4.5 ^1 of this reaction were 
transferred into each of the four pre-warmed sequencing mixes and incubated at 37^C 
for 5 min. Five ^1 of Stop Solution (Section 2.2) were then added to each tube to 
terminate the labeling reaction. The tubes were heated at 75-80 ^C for 2 min and 1.5 
to 2jid of each heated sample were loaded into the appropriate well of a sequencing 
gel. To make a 8% sequencing gel (Sambrook et al., 1989), 20ml 20 % acrylamide 
(Section 2.2), 30ml urea mix (Section 2.2) and 0.4ml 10% ammonium persulfate were 
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mixed. Fifty ^1 ofTEMED were added to the mixture, mixed and immediately poured 
into the sequencing gel mold. Electrophoresis was performed at constant power of 
55WwithlXTBE buffer. 
The nucleotide sequences of primers for sequencing are: 
Universal primer: 5'GTTTTCCCAGTCACGAC3', 
Reverse primer: 5'CAGGAAACAGCTATGAC3’ 
pCR® 2.1 vector specific primer: 5'GCCAGTGTGCTGGAATT3 ’ 
IGF-I specific primer (S3): 5 'AGATGCGGGCAATGTCACATCTCA5 ‘. 
The position of the IGF-I specific primer (S3) is shown in Fig. 2.1. 
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2.4 Results and Discussion 
Fig. 2.2 shows the strategy of cloning the common carp IGF-I 5'-flanking 
region The common carp genomic DNA was first completely digested by selected 
restriction enzymes separately. Then, the cassette with the restriction site of 
corresponding restriction enzyme was ligated to the genomic DNA. Since the 5'end of 
the cassette is not phosphorylated, a nick will occur within the ligation site of the 5'-
end of the cassette and 3'-end of the target DNA. Jn the first PCR, second strand 
synthesis from the cassette primer C1 was stopped at the nick so that non-specific 
amplification was prevented. Only the second strand synthesized from IGF-I gene 
specific primer S1 was utilized as the template ofDNA synthesis of complementary 
strand from the cassette primer C1. Then, the unknown region was amplified in more 
specific and in higher yield during second PCR using inside primers (C2 and S2). 
Using common carp genomic DNA digested by Hind EI restriction enzyme as 
template, the PCR product was cloned into pCR® 2.1 vector. Fig. 2.3 shows the PCR 
products after agarose gel electrophoresis and EtBr staining. It was found that the one 
using Hind HI cut genomic DNA as template a the largest size PCR product of � 8 0 0 
bp. Therefore, the corresponding band was excised and purified from the gel. The 
DNA fragment was then cloned into pCR® 2.1 vector and labeled as IGFlP. 
Nucleotide sequence determination was carried out for this clone and the 
sequence is shown in Fig. 2.4. It was found that the insert includes 840 bp nucleotide 
sequence encoding the proximal 5'-UTR and the first part of the signal peptide of 
common carp IGF-I cDNA. Therefore, the clone, IGFlP, contains the 5'-flanking of 
the common carp IGF-I gene. 
Sequence analysis (Fig. 2.5) revealed that the 5'-flanking region of common 
carp IGF-I gene is highly conserved when compared with the sequence ofIGF-I gene 
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Common carp Genomic DNA  
Restriction Digestion 
• 
： 1 ： 1  
1 Restriction Fragment ； Restriction Fragment 
^ Cassette 
Cassette Ligation r  
C1 i S1 
5 ' Z ^ t ~ 3， 
n I — 1 
TGF-T Gene Fragment (unknown) known ~ ~ 
3， � 丨 'S' 
First Round PCR Using C1 and S1 IGF-I Sequence From cDNA 
C2 S2 
5， — — 3， 
3，l 1 15， 
Second Round PCR Using C2 and S2 
令 
5’ 3， 
I Amplified IGF-I 
3^~ 丨 '5' promoter 
Fig. 2.2 Strategy of cloning the common carp IGF-I 5'-flanking region. Labeled 
arrows above the fragments represent the relative positions and 5，to 3，direction of 
the primers used in Takara PCR 
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Lane 1— X Hind EE marker 
Lane 2— PCR product using Eco RI digested common carp 
genomic DNA as template 
Lane 3— PCR product using Hind EI digested common carp 
genomic DNA as template (cloned & sequenced) 
Lane 4-- PCR product u s i n g ^ a I digested common carp 
genomic DNA as template 
Lane 5— 1 kb marker 
1 2 3 4 5 
i ^ H I 
| ^ o ^ ^ ^ ^ ^ ^ M ^ T ^ 
RPGR^^^^^^^^^^^^^^^^IsSii^fl • • 4 ? ^ ^ ^ ^ ^ ^ ^ ^ ^ ^ ^ ^ ^ ^ R Z 2 S l ^ ^ ^ ^ H ^ ^ ^ ^ ^ ^ ^ ^ ^ I ^ H ^ ^ g S 
m^^K^^^^^^^^^^^^^^^^^^^^^ESS^M ^^^^^^ai m^^^^^m 
^ ^ ^ ^ ^ ^ ^ ^ ^ ^ ^ ^ ^ ^ ^ ^ ^ ^ ^ ^ ^ ^ ^ ^ ^ ^ ^ ^ ^ ^ s 
^ ^ S ^ ^ ^ ^ H H | ^ ^ ^ ^ ^ H | ^ H 
^ g j ^ ^ ^ m ^ ^ ^ ^ ^ ^ H I^^ ^R^^ 3^ 
^ ^ ^ ^ ^ H H ^ H 
^^^^^^^HU^^^^^^P^^^^El^^^^^H^^^H ^ 1 kb 
^^^^^^^H|P||^^^^^^^^y^^^HH^^^^^^^^^| ^ B — 
Fig. 2.3 The DNA gel (after EtBr staining) showing the 2"^  round PCR products 
using gene specific primers (S1 and S2) designed from the common carp IGF-I cDNA 
clone and the cassette primers (C1 and C2) provided by the Takara kit. 
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840 AGCTTTTGAA GAGAC6CGC6 AAAAGAAGTC GCTTTGGTCT GAAGTGGAAA CCATACGATA 
780 AACATC6AGG ATTCAAACG6 GACATTGACG AGACAAATGC TGTCATTATT GAGCATTTTG 
720 AATTATATTA GAGATATACT AGACATGGCT GCCACTGCTC AGTAACACAA ACCACTATCA 
660 TTACAATTTT ATAGATATAT TACAAGAACT TTCAGTTTTA AAATCTTTTA GATGATGCTT 
600 AGCTTTATCT CAGCTAATTG CGCCCCGAAA ACATAGGCTA CTATAGAAAT TCATTTAAAA 
540 AAAGTTAATC TCATATAAAT 6CATTAAAAA AG6CACACGC TGGCAAGTAT ACA6AGATGA 
480 AAAA6ACACC GTGCAAATTA CGCAT6GGAG TGTCTCTAAA TTCAACTTCT GTCCTTTTCT 
420 AAAAACTCAC CACTTTCTCT AACTCCCTTA TTCGTTTTCA TTCTGCAATG CAATCTTTTC 
360 TGTTCTGTTA GTAAGTTCCA AAATGATCCA AATTCGAGCC TATTCTAAGA AACAGATGAC 
300 GTTATTTGAC A66GTGCCCA AAATCCTTAA TGAGTAACTT A6CAA6A66A GAAGGCAAAT 
240 GCTGCCCCAG CTGTTTCCTG TTGAAAATGT CTCTGTAATG TAGATAAATG TGAGGGATTT 
180 TCTCTCCAAA TCCGTCTCCT GTTCGCTAAA TCTCACTTCT CCACAACGAG CCTGCGCAAT 
Primer S3 
4  120 6GAACAAA6T CGGAATATTG AGATGTGACA TTGCCCGCAT CTCATCCTCT TTCTTGCTTT 
Primer S2 
60 TTAMSACTT CAAACAAGTT CATTTTTGCT GGGCTTTTGC TGGAGACCCA AGGGATGTCT 
MafcThrS erAsnLysPh eIlePheAla GlyLeuLeuL euGluThrGl nGlyMetSer 
Fig. 2.4 Nucleotide sequence of the 5'-flanking region of common carp IGF-I 
gene (clone IGFlP). Labeled arrows above the sequence represent the position and 5’ 
to 3，direction of the primers used in Takara PCR and DNA sequencing. The ATG 
encoding the first Met in the IGF-I signal peptide is underlined; the nucleotide 
sequence of the signal peptide is boxed. 
52 
AGCTTTTGAA GA6ACGCGCG AAAA6AAGTC GCTTTGGTCT GAAGTG6AAA CCATACGATA 
AACATCGAGG ATTCAAACGG GACATTGACG AGACAAATGC TGTCATTATT GAGCATTTTG 
AATTATATTA GAGATATACT AGACATGGCT GCCACTGCTC AGTAACACAA ACCACTATCA 
TTACAATTTT ATAGATATAT TACAAGAACT TTCAGTTTTA AAATCTTTTA GATGATGCTT 
AGCTTTATCT CAGCTAATTG CGCCCCGAAA ACATAGGCTA CTATAGAAAT TCATTTAAAA 
Common carp AAAGTTAATC TCATATAAAT GCATTAAAAA AGGCACACGC TGGCAAGTAT ACAGAGATGA 
Common carp AAAAGACACC GTGCAAATTA CGCATGGGAG TGTCTCTAAA TTCAACTTCT GTCCTTTTCT 
Coho salmon 85.3% identity in 374 bp overlap AA*G*C 
Seabream 83.4* identity in 362 bp overlap ****T* 
Chicken 70.5% identity in 295 bp overlap CA***C 
Human $6.2% identity in 331 bp overlap ****** 
Common carp AAAAACTCAC CACTTTCTCT AACTCCCTTA TTCGTTTTCA TTCTGCAATG CAATCTTTTC 
Coho salmon T*T**--**A *T*A*CA*TG *GA*TT*-** CA**-*AA** AG**TTG*GA AG*G*GGG*-
Seabream TCT*T**--T G*TC*GAA** -***AA*CA* G**T*AGAG* GATCAA***T ***** * 
Chicken CTT*TT*TC* GTGGCAGCG* **GCTTT**T GC*TGC*AAC CC**CAGTCA *T*AT*CACA 
Human *TGGCAG**T A*G*A*-*T* **TGT*TGCG AA*CC*G*** --**AAC*CA **T******A 
Common carp TGTTCTGTTA GTAAGTTCCA AAATGATCCA AATTCGAGCC TATTCTAAGA AACAGAT---
Coho salmon G**AG**GGT CC***CCTT* **GA****** *****A*T** C********* **AGT**AAA 
Seabream C******--* *A**AAAAA* ***AA*AAAG **AAAA**-- --AAAA**A* G*G*A**… 
Chicken *TC*T*TAA* *GGGAAAAA* T*TGCT**TG TGC**T**TT *TAAAATGC* **GGT**---
Human A* *GA* AA**A*G*TT CTG**C*-*T *G**TT*--A A**G*A***-——GT**  
V V 
Common carp GACGTT ATTTGACAGG GTGCCC---A AAATCCTTAA TGAGTAACTT AG  
Coho salmon TGAT****** ******ATAT ****** * ********** ***A***T** ** 
Seabream ****** ******ATAT ****** * ********** ***A****** ** 
Chicken **T*** ***»*T**CC A*****AAA* **G******C *CG******* T*CCAGAAGA 
Human **T*** *****T**CC A*****AAA* **G******C *C*A****** T*CCAGAAGA 
V 
Common carp ---CAAGAG- GAGAAGGCAA ATGCTGCCCC AGCTGTTTCC TGTTGAAAAT GTCTCTGTAA 
Coho salmon G*T***- ********** ********** ********** ********** ****G***** 
Seabream G*C***- T**G****** ********** ********** ********** ****G***** 
Chicken GGGAG****A ********** *****C**** ********** ***CT*C*G* ****G***** 
Human GGGAG****A ********** ***T*C**** ********** ***CT*C*G* ****G***TT 
Common carp TGTAGATAAA TGTGAGGGAT TTTCTCTCCA AATCCGTCTC CTGTTCGCTA AATCT  
Coho salmon ********C* ********** ********T* ********** *A******** ***** 
Seabream ********** ********** ********T* ********** ********** ***** 
Chicken ********** *****-**** *******--* *****C***T *****T**** *****CACTG 
Human ********** *****-**** *******--* *****C***T *****T**** *****CACTG 
Common carp -CACTTC--T C CACAACGAGC CTGCGCAATG GAACAAAGT- CGGAATATTG 
Ooho S6Ll&lOXl —******_—* •_•__ — — — _* **A******* ********** *********_ ********** 
Se^ b^lTddXIV —******__* _ — — ____ — _* **A******* ********** ********** ********** 
Chicken T****G*--* AAAATCAGAG **G*TA**** ********** ***T*****C *TC******* 
Human T****G*--* AAATTCAGAG **G*TA**** ********** ***T*****C *TC**A**** 
Common carp A6ATGTGACA TTGCCCGCAT CTCATCCTCT TTCT-TGC-- TTTTTAATGA CTTCAAACAA 
Coho salmon ********** *****T**** **T****A** ****-CA*TG ********** ********** 
Seabream ********** ********** ********** ****-CC*CG ********** ********** 
Chicken *A******** ****T*T**A *ATC**ACA* C***C**G-- A***CTT*TT TC***TCATT 
Human *A******** ****T*T**A *ATC***CA* C***C**G-- A***CTT*TT GC*TC*TT*T 
Common carp GTTCATTTTT GCT-GGGCTT T TGCT 6GA6ACCCAA GGG-ATGTCT 
Coho salmon ********** ***Q****** *GTCGG***- ********GT ***-****** 
Seabream *********c **c-****** *GTC-T***- ********GT ***G****** 
Chicken AC*GC*AACA AA*TCATT*C C A*A- CTTTG*A*TT TTA-*GAAGC 
Human TCCTGC*AAC CAA-TTCA** * *CAG ACTTTGTACT TCA-GAAG*A 
Fig. 2.5 Comparison of nucleotide sequences of the 5，flanking region in 
common carp IGF-I gene with similar regions of the coho salmon, seabream, chicken 
and human IGF-I genes; the corresponding percentage identity is shown. Identical 
nucleotides are indicated by *. Gaps are introduced to maximize homology and are 
indicated by -. Transcription start sites described Kajimoto and Rotwein (1991) for 
chicken IGF-I gene are marked by v. The TATA-like motif and HNF-1 sequences 
(Kajimoto and Rotwein, 1991) are shaded. 
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from coho salmonfKoval et al., 1994), seabream (Fimkenstein et al., 1996), chicken 
(Kajimoto and Rotwein, 1991)，and human (Rotwein et al., 1986). Comparison of the 
region upstream from the first methionine with IGF-I sequence from the four 
vertebrates demonstrated a very highly conserved region up to the sequence TTTTCT, 
which start at -368 nucleotides upstream of the first methionine of the prepeptide. By 
contrast, the nucleotides upstream of the -368 nucleotides shows very little similarity 
among the four vertebrates. Within the conserved region, the common carp IGF-I 5'-
flanking region has about 70 % identity with chicken and human and, even higher 
with more than 80 % identity among different fish species. 
As in the coho sahnon, seabream, chicken and human IGF-I genes (Kavsan et 
al., 1993), there is a TATA-like consensus sequence approximately 250 bp 5’ 
upstream of the first methionine of the common carp IGF-I gene. A putative initiator 
sequence, suggested for the coho salmon, seabream, chicken and human is also 
present in the common carp. This sequence, which is identical to that found in the 
chum salmon IGF-I gene (Kavsan et al., 1994)，contains a potential hepatocyte nuclear 
factor 1 (HNF-1) binding site (Kulik et al., 1995). It was found that the HNF-1 has a 
potent stimulatory action the activity of the promoter of the salmon IGF-I gene in 
transient transfection experiments. Mutating this sequence to a variant which is no 
longer capable of exhibiting HNF-1 binding resulting in the loss of the stimulatory 
effect. 
Li conclusion, we have successfully cloned the promoter region of common 
carp IGF-I gene and it was used as a probe to characterize the IGF genomic clones 
obtained from screening of a common carp genomic library. 
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CHAPTER 3 ISOLATION OF GENOMIC CLONES CARRYING THE 
IGF-I GENE 
3.1 Introduction 
To examine the phylogeny, biochemistry and molecular biology of insulin-like 
growth factor (IGF) in local fish species, we started our studies using a local tropical 
fish, the common carp {Cyprinus carpio). We have demonstrated that IGF-I Ea2 form 
is the predominantly expressed form of IGF in common carp (Liang et al., 1996). 
Multiple forms of IGF-I and one form of IGF-E cDNA sequences were identified in 
rainbow trout (Shamblott and Chen, 1993). Two nonallelic IGF-I genes were cloned in 
chum salmon (Kavsan et al., 1994; Kavsan et al., 1993). These two IGF-I genes 
appeared to be more compact than the mammalian and avain genes, being less than 20 
kb in length. As in other species, however, the mature IGF-I peptide consists of 70 
amino acids encoded by exon 2 and 3. 
Li common carp, however, only one subtype ofIGF-I and no IGF-H was found 
so far. On the other hand, genomic Southern blot analysis performed on carp 
demonstrated that there could be more than one IGF gene in the genome of common 
carp. The solution of this apparent dicotomy is dependent upon the isolation and 
cloning of IGF gene(s) from common carp. Li this study, we screened a common carp 
genomic library for IGF genes to see if we could identify the IGF gene or genes in the 
genome of common carp. The probe encodes conserved region of common carp IGF-I 
cDNA. Presumably, it can hybridize to both IGF-I and -H nucleotide sequences. 
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3.2 Materials 
LB ^juria-Bertani) medium (Section 3.3.1) 
Bacto-tryptone 10g 
Bacto-yeast extract 5g 
NaCl 10g 
Add ddH2O to 1 liter, sterilize the buffer by autoclaving for 20 min at 151b/sq. in. 
liquid cycle. 
LB plate (Section 3.3.1) 
Composition the same as LB medium except with 1.5% agar. 
NZY medium (Section 3.3.2 and 3.3.3) 
NZ amine 10g 
NaCl 5g 
Bacto-yeast extract 5g 
MgSO4.7H2O 2g 
Add ddH2O to 1 liter, sterilize the buffer by autoclaving for 20 min at 151b/sq. in. 
liquid cycle. 
NZY top agarose (Section 3.3.2 and 3.3.3) 
Composition the same as NZY medium except with 0.7 % agarose. 
NZY plate (Section 3.3.2 and 3.3.3) 
Composition the same as NZY medium except with 1.5% agar. 
Denaturation buffer (Section 3.3.3) 
1.5MNaCl 
0.5MNaOH 
Neutralization buffer (Section 3.3.3) 
1.5MNaCl 
lM Tris-Cl, pH 7.5 
20X SSC (Section 3.3.3) 
175.3gNaCl 
88.2g sodium citrate 
Add ddH2O to 1 liter, adjust pH to 7.0 with 10N NaOH, sterilize the buffer by 
autoclaving for 20 min at 151b/sq. in. liquid cycle. 
10% SDS (Section 3.3.3) 
lOOgSDS 
Add ddH2O to 1 liter, heat to 68^0, adjust pH to 7.2. 
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SM (Section 3.3.2,3.3.5 and 3.3.6) 
NaCl 5.8g 
MgSO4.7H2O 2g 
lM Tris-Cl, pH7.5 50 ml 
2% gelatin solution 5ml 
ddH2O to 1 liter 
Add H2O to 1 liter, sterilize the buffer by autoclaving for 20 min at 151b/sq. in. liquid 
cycle. 
Binding Buffer (Section 3.3.6) 
Solution of sodium perchlorate buffered with Tris-HCl. 
Denaturing solution for alkaline (Section 3.3.8) 
1.5MNaCl 
0.5MNaOH 





3.3.1 Preparation of the Plating Host Cells 
Fifty ml LB medium (Section 3.2) (containing 0.2% maltose and 10 mM 
MgSO4) in a sterile Erlenmeyer flask were inoculated with a single colony of the XL-
1 blue bacterial host. The culture (50ml) was grown ovemight with shaking at 30^C. 
This temperature ensured that the cells would not overgrow as phage can adhere to 
dead as well as live cells. The cells were centrifuged down in a sterile conical tube for 
10 min at 2,000 rpm on the following day. The media were carefully removed and the 
cell pellet was gently resuspend in � 1 5 ml of 10 mM MgSO4. The cells were then 
diluted to OD600=0.5 with 10 mM MgSO4 and stored at 4^C. 
3.3.2 Phage Titering 
Serial dilutions (10-l，10-2，10-3，10-4，10-5，i0-6 and 10_7) ofanaliquot ofthe 
phage library or phage stocks were prepared in SM buffer (Section 3.2). Five ^1 of 
each dilution of phage were added to 100 ^1 OD600=0.5 host cell in 7 separate culture 
tubes. After incubated at 37^0 for 15 min，3ml 4S^C NZY top agarose (Section 3.2) 
was added and the content was plated on each 100 mm NZY agar plate (Section 3.2). 
The plates were allowed to harden at room temperature for lOmin. The plates were 
then incubated at 37®C ovemight. The number of plaques formed were counted and 
the plaque forming unit Qp.f.u.) were determined. 
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3.3.3 Primary Screening of Common Carp Genomic Library 
A common carp genomic library was obtained from Stratagene，La Jolla, USA. 
Lambda FDC E was used as vector in this library and the averaged insert size is about 
15 kb. The library was plated out at a concentration of 50,000 p.f.u. per agar plate 
(150mm in diameter) with 600 ^1 OD600=0.5 host ceU/plate and 7 ml NZY top 
agar/plate. Totally 600,000 p.f.u. were spreaded on 12 NZY plates. The plates were 
incubated at 37^C until the plaques were just visible to the naked eye. The plates were 
then put in a refrigerator at 4^0. This step was important in preventing top agarose 
from sticking to the nylon filter. Dry nylon filter were laid onto the plates for 2 min 
and the filters were pricked with a needle through the membrane into the agar for 
orientation. Filters were peeled off from the plates and laid, plaque side up, on a 3MM 
paper saturated with denaturation solution (Section 3.2) for 2 min. The filters were 
then transferred to a 3MM paper saturated with neutralization buffer (Section 3.2). 
After 4 min, the filters were submerged in 2X SSC (Section 3.2) for 30 sec to rinse. 
The filters were then placed on dry 3 MM paper and air dried for about 25 min. The 
DNA was crosslinked to the filters for 4 min in an UV crosslinker (Fotodyne). The 
plates were stored in a 4 ^C refrigerator. 
The common carp IGF-I cDNA Rsa I fragment was first purified using the 
method described in Section 2.3.5 after agarose gel electrophoresis and then labeled 
with oc32p_dCTP using an Amersham nick translation kit (Section 3.3.4). The filters 
were prehybridized at 65^C for 1 hr and then hybridized at 65^C for 2hr in Rapid-hyb 
buffer (Amersham). After hybridization, the filters were washed twice in 2X SSC, 
0.1% SDS (Section 3.2) at 65^C for 30 min and exposed to Kodak BIOMAX™ MR 
film at -70OC for 4 days between intensifying screens. 
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3.3.4 Preparation of Radioactive Nucleic Acid Probes 
The radioactive nueleic acid probes were prepared using the Nick Translation 
Kit 0S[5OOO) ofAmersham. 
The DNA probes were diluted to a concentration of 50ng/fil in ddH2O. Li a 50 
|il reaction, 5 ^1 of 1 |ig DNA sample, 10 ^1 nucleotide buffer solution, 5 ^1 oc-32p 
dCTP (PB10205, Amersham), 25 ^1 water and 5 |ul enzyme solution were added to a 
clean microcentrifuge tube. The content was mixed gently by pipetting up and down 
and then incubated at 15®C for 60 min. However, if desired, any incubation time 
between 30 min and 3 hr may be employed. The reaction was then stopped by the 
addition of5 ^1 of0.2M EDTA, pH8.0 followed by heat treatment at 100OC for 5 min. 
To remove unincorporated nucleotides, the labeled probes were purified by passing 
through NucTrap® push columns (Stratagene). 
3.3.5 Purification of the Positive Clones 
Fourteen positive clones were picked from the NZY agar plates of primary 
screening and resuspend in 0.5 ml SM (Section 3.2) with 5p,l chloroform added. They 
were shaken at room temperature for 3 hr. After centrifugation to remove cell debris 
and agar, the supematants containing the phage were stored at 4^C. These phage 
stocks were then diluted 1000X. About 100 p.f.u. was plated out on NZY agar plates 
(90 mm in diameter) with 200 i^l OD600=0.5 host celVplate and 2.5 ml NZY top 
agar/plate. The plates were incubated in 37^C until the plaque with a diameter of 
about 2nun. Filters lifting and hybridization with the same cDNA probe at the same 
hybridization condition as described in Section 3.3.3 were repeated until all plaques 
showed positive signals. Ten isolated plaques (P1 to P10) with positive signals were 
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picked and resuspend in 0.5ml SM with 5 i^l chloroform after a total of three more 
rounds of screening (i.e. until plaque-purified). 
3.3.6 Purification of DNA from Lambda Phage Using Sephaglas™ 
PhagePrep Kit (Pharmacia) 
The 10 positive clones, each contain lO^to 10^  phages, were plated on 150 mm 
NZY agarose plates in an NZY soft agarose mix containing appropriate bacterial host 
cells for phage infection separately. Over a 6 to 10 hr period, the plaques from each 
individual phage enlarged and became confluent, effectively lysing most of the host 
cells. After confluent lysis was achieved, the soft agarose layer was harvested by 
scraping with a bent Pasteur pipette into a 50 ml polypropylene tube. The plate was 
rinsed with 8 ml SM buffer (Section 3.2) and the buffer was pooled with the scraped 
agarose. Seven hundred \x\ chloroform was then added to the mixture and incubated 
with vigorous shaking for 15 min at 37°C. The agarose was separated from solution 
containing phage by centrifugation at 6,000 rpm for 10 min at 4°C. About 8 ml 
supernatant was decanted from the agarose pellet and was ready for preparation of 
phage DNA. 
P p * y T  
Using the Sephaglas PhagePrep Kit fPharamica), the 8 ml phage supernatant 
was mixed with 2 ml DEAE Sephacel provided by the kit and incubated for 3 min at 
room temperature with gentle rocking to keep the matrix suspended. Then, the tube 
was centrifuged at 1,000 x g for 5 min and the supernatant was transferred to a new 
tube to remove bacterial DNA and RNA. This DEAE treatment step was repeated 
twice. Eighty i^l of glacial acetic acid was then added to the supernatant. The tube was 
vortexed and incubated at room temperature for 2 min. The addition of acetic acid to 
the supernatant caused the phage to aggregate and bind efficiently to the Sephaglas 
61 
PH, provided by the kit, added later. Then, 800 i^l of Sephaglas PH were added to the 
phage/acetic acid mixture. The tube was vortexed gently every min and incubated for 
5 min at room temperature. The Sephaglas was then pelleted by centrifugation at 
1,000 X g for 3 min and the supernatant was carefully removed. The Sephaglas was 
then resuspend by adding 1 ml of Binding Buffer (Section 3.2) and transferred to 
minicolumn provided by the kit. The column was placed in 12 x 75 mm centrifuge 
tube and then spun at 300 x g for 3 min to remove the supernatant. This wash step was 
repeated once to remove the protein and help binding of DNA to the Sephaglas. The 
Sephaglas pellet was spun briefly and allowed to air dry for 10 min to remove any 
residual ethanlol. Finally, the DNA was eluted by 400 \xl preheated water (55-60°C). 
The absorbance of the DNA at 260 nm and 280nm was measured to detect the yield of 
DNA. 
3.3.7 Restriction Enzyme Digestion Relaese ofInserts 
One |ig of phage DNA of each of the clones was digested with 10 units oiXba 
I，Xba I + Eco RI, and Xba I + Hind m for 4 hr at 37 °C in approximate buffer 
separately. Xba I restriction enzyme cut at the restriction sites of the multiple cloning 
site of the Lambda FEX® H vector flanking the 5' end and 3, end of the genomic DNA 
insert and the insert itself. Agarose gel electrophoresis was performed and the digested 
DNA was fractionated on 1% (w/v) IX TAE agarose gel. 
3.3.8 Capillary Transfer of DNA to Nylon Membrane Under Alkaline 
Condition 
After agarose gel electrophoresis, the DNA in the gel was denatured by 
soaking the gel in the denaturing solution (Section 3.2) for 45 min with constant 
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gentle agitation. A piece of nylon membrane (Hybond N, Amersham) was cut to the 
exact size as the gel. A sheet of 3MM paper was cut to the same width as the gel but 
long enough to form a bridge between the buffer reservoir of the transfer. It was 
wetted by the alkaline transfer buffer (Section 3.2). The gel was then removed from 
the denaturing solution and inverted so that its underside faced upward. The wet nylon 
filter which has been soaked in the aUcaline transfer buffer was placed onto the gel. 
Any air bubble between the membrane and the gel was removed. Three wet 3MM 
papers were placed on the top of the nylon filter and any air bubble trapped was 
smoothed out by a glass rod. A stack of paper towels (5-8cm high) was then placed on 
the top of the 3MM papers. A glass plate was put on the top of the stack and a 500g 
weight was placed on the top (Sambrook et al., 1989). 
3.3.9 Southern Analysis of the 10 Positive Clones 
The IGFlP insert (obtained from Chapter 2) containing the 5'-flanking region 
of common carp IGF-I gene, together with the following common carp IGF-I cDNA 
fragments: the Rsa I fragment encoding for a part of signal peptide and the B, C, A, D 
domains, and the Xho 历 fragment encoding for part of the E domain and the 3'-UTR 
(Liang et al., 1996) were prepared as described in Section 2.3.5. These three probes 
were labelled with a^^P-dCTP using an Amersham nick translation kit (Section 
3.3.4). The blots were first hybridized with the Rsa I fragment. The blots were 
hybidized and washed at the same hybridization condition as described in Section 
3.3.3, and exposed to Kodak BIOMAX™ MR film at -7QOC for 1 to 4 days between 
intensifying screens. The same blots were then washed twice in 100^C water for 10 
r p * * 
min to wash away the radioactive probe, and exposed to Kodak BIOMAX MR film 
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at -70^C for 10 days to ensure no radioactive probe remain in the blot. The blots were 
then hybridized with the Xho R) fragment and then with the IGFlP insert, and washed 
under th^ same condition as described above. The blots were then exposed to 
BIOMAX™ MR fihn at -70^0 for 1 to 4 days. 
3.3.10 Restriction Mapping of the Clone P1 
After Southem analysis, 1 out of the 10 clones was found to contain the entire 
gene, P1. Several restriction enzymes (include Ava H, Eco RI, Hind HI, Kpn I, Nco I， 
Sma I, Sst I，Xba ^ were used to digest the P1 clone and the condition was the same as 
in Section 3.3.7. Agarose gel electrophoresis was performed and the digested DNA 
was fractionated on 1% (w/v) IX TAE agarose gel. Capillary transfer of DNA to 
Nylon membrane (Amersham) under alkaline condition (Section 3.3.8) and Southem 
analysis using the same three probes as described in Section 3.3.9 were carried out. 
3.3.11 Subcloning of the Fragments of the Clone P1 into Plasmid Vector 
The fragments released from the Hind HI restriction enzyme digestion were 
excised from the agarose gel. Gene Clean (Section 2.3.5) was performed to purify the 
DNA firagements. The eluted DNA fragments were ligated to Hind EE cut and 
dephosphorylated pUC18 vectors (Pharmacia). After ligation, the vectors were 
transformed into DH5a competent cells as described in Section 2.3.7. 
3.3.12 IGF-I Specific PCR 
Fifty ng of clone P1 and lOO i^g of carp genomic DNA (prepared from Section 
2.3.1) were used for PCR, using the Perkin Elmer GeneAmp 9600 Thermocycler and 
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the Expand™ Long Template PCR System (Boehringer Mannheim). The cycle profile 
is given as below: 
IX 93�C 2min 
10X 93�C 10 s 
55°C 30 s 
68�C 15min 
20X 93�C 10 s 
55�C 30 s 
68�C 15 min 
+ cycle elongation of 20 s for each cycle 
IX 68°C 7min 
Li each round of PCR, 2.5 units of an enzyme mixture of Taq and Pwo DNA 
polymerases (Boehringer Mannheim) were used and 15 pmole of each primer were 
used in a reaction of 50 |il. IGF-I specific primers were designed from the starting of 
common carp cDNA signal peptide and the end of common carp E domain. The 
relative position of the primers could be seen in Fig. 3.1. Both regions are in fact 
conserved in the four form of IGF-I mRNAs in chinook sahnon (Wallis and Devlin, 
1993). The nucleotide sequences of primer set for carp IGF-I is : 
IGF-5' primer: 5'GATGTCTAGCGGACATTTCTTC3', and 
IGF-3' reverse primer: 5'CTAAATGCGATAGTTTCTTCCC3'. 
Ten \xl of PCR products were fractionated in a 1% (w/v) IX TAE agarose gel. After 
EtBr staining, the samples were transferred onto Hybond-N nylon membrane 
(Amersham) by capillary alkali-transfer ovemight (Section 3.3.8) and Southern 
analysis using the common carp IGF-I cDNA Rsa I probe as described in Section 3.3.9 
was carried out. 
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IGF-I ‘ Primer 
� ， \ Rsa\ Pst\ Xho\ Rsa\ Xho\ 
Pst ‘ ^ ^ 1 j • j I Xho I 
5' l l 5' untranslated~~ ~ ~ „ ~ ~ F " ^ ~ . | _ | “ ~ ~ 3' untranslated~~ I 3,  
region Signal peptide B C A D t region  
^ ^^^^^IGF-I3 
_ _ Rsa I fragment reverse primer 
,^^^_^^^^ Xho la fragment 
_ I X/iolb 
fragment 
I I I I I I I I I 
0 100 200 300 4 0 0 500 600 700 800 900 
Nucleotide 
Fig. 3.1 The relative positions of the Rsa I fragment, Xho ft fragment and IGF-I 
specific primers in the common carp IGF-I Ea2 cDNA (Liang et al., 1996). 
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3.3.13 Amplification ofIntrons from the Clone P1 Using PCR 
According to the structure of salmon IGF-I gene (Kavsan et al., 1993), primers 
were designed to amplify introns from the clone P1 using PCR. Fifty ng of clone P1 
and lOO i^g of carp genomic DNA (prepared from Section 2.3.1) were used for PCR, 
using the Perkin Ehner GeneAmp 9600 Thermocycler and the Expand™ Long 
Template PCR System OBoehringer Mannheim). The cycle profile is given as below: 
IX 93�C 2 min 
10X 93�C 10 s 
55�C 30 s 
68�C 4min 
20X 93�C 10 s 
55�C 30 s 
68�C 4min 
+ cycle elongation of 20 s for each cycle 
IX 68�C 7min 
Jn each round of PCR, 2.5 units of an enzyme mixture of Taq and Pwo DNA 
polymerases (Boehringer Mannheim) were used and 15 pmole of each primer were 
used in a reaction of 50 ^1. The position of the primer could be seen in Fig. 3.2. The 
nucleotide sequences of primer sets for amplification of introns are: 
Litron 1， 
5，primer (IG2) 5 'ATGTCTAGCGGACATTTCTTCCA3', and 
3 ’ reverse primer (IG3) 5，ACGAGAGACAGCGCATGGTACA3，； 
Litron 2, 
5，primer (IG4) 5'GAGACAGGGGCTTTTATTTCA3', and 
3，reverse primer (IG5) 5'CGTCTTCAACTAGGCCCATAT3 ‘； 
Mron 3， 
5，primer (IG6) 5'CCCGTAAAGCCCGGCAAAACT3', and 
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I5‘ untranslated region  
TCCAAATCCGTCTCCTGTTCGCTAAATCTCACTTCTCCACAACGAGCCTGCGCAATGGAACAAAGTC 67 
Signal peptide.. 
GGAATATTGAGATGTGACATTGCCCGCATCTCATCCTCTTTCTTGCTTTTTAATGACTTCAAACAAGTTCA 13 8 
MetThrSerAsnLysPheI 6 
Prlmer IG2 • 
TTTTTGCTGGGCTTTTGCTGGAGACCCAAGGGATG TCT AGC GGA CAT TTC TTC CAG GGG CAT 200 
1ePheAIaGlyLeuLeuLeuGluThrGlnGlyM&t Ser Ser Gly His Phe Phe Gln Gly His 27 
Primer IG3 A  
Rsa I  
TGG TGT GAT GTC TTT AAG TGT ACC ATG CGC TGT CTC TCG TGC ACC CAC ACC CTC 254 
Trp Cys Asp Val Phe Lys Cys Thr Met Arg Cys Leu Ser Cys Thr His Thr Leu 45 
B domain 
TCA CTG GTG CTG TGC GTC CTC GCG TTG ACT CCC GCG ACA CTG GAG GCG GGG CCG 308 
Ser Leu Val Leu Cys Val Leu Ala Leu Thr Pro Ala Thr Leu Glu Ala Gly Pro 63 
Pst I  
6AG ACG CTG TGC GGG GCG GAG CTT GTA GAC ACG CTG CAG TTT GTG TGT GGA GAC 362 
Glu Thr Leu Cys Gly Ala Glu Leu Val Asp Thr Leu Gln Phe Val Cys Gly Asp 81 
Primer IG4 Primer IG5  
^ 4  
C domain  
A6G GGC TTT TAT TTC AGC AAA CCA ACA GGA TAT GGG CCT AGT TCA AGA CGG TCA 416 
Arg Gly Phe Tyr Phe Ser Lys Pro Thr Gly Tyr Gly Pro Ser Ser Arg Arg Ser 99 
A domain  
CAC AAC CGT GGC ATT GTG GAT GAA TGC TGC TTT CAG AGC TGT GAG CTG AGG CGC 470 
His Asn Arg Gly Ile Val Asp Glu Cys Cys Phe Gln Ser Cys Glu Leu Arg Arg 117 
Primer IG6 • 
Xho I D domain E domain.Ksa I. 
CTC GAG ATG TAT TGT GCA CCC GTA AAG CCC GGC AAA ACT CCA CGA TCC GTA CGA 524 
Leu Glu Met Tyr Cys Ala Pro Val Lys Pro Gly Lys Thr Pro Arg Ser Val Arg 135 
GCG CAA CGG CAT ACA GAC AGC CCA AGG ACA GCA AAG AAA CCT TTA CCT GGA CAA 578 
Ala Gln Arg His Thr Asp Ser Pro Arg Thr Ala Lys Lys Pro Leu Pro Gly Gln 153 
Xho I  
AGC CAC TCT TCC TAT AAG GAG GTT CAT CAG AAG AAC TCG AGC AGA GGA AAC ACA 632 
Ser His Ser Ser Tyr Lys Glu Val His Gln Lys Asn Ser Ser Arg Gly Asn Thr 171 
Primer IG7 
M  
3‘untranslated region  
GGG GGA AGA AAC TAT CGC ATT TAGAGGACAGTAAGGCGAATGGCTGAGAGAGACAAGTGAAACT 696 




Fig. 3.2 Nucleotide sequence and the predicted amino acid sequence of the 
common carp IGF-I cDNA clone (Liang et al., 1996). Labeled arrows above the 
sequence represent the positions and 5, to 3，direction of primers used in PCR for 
amplification of introns. 
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3，reverse primer Q.G1) 5 ‘CTAAATGCGATAGTTTCTTCC3 ‘. 
Ten ^1 ofPCR products were fractioned in a 1% (w/v) IX TAE agarose gel. The PCR 
products were cloned into pCR® 2.1 vector as described in Section 2.3.6. DNA 
sequencing was performed using the Universal primer and Reverse primer as 
described in Section 2.3.11. 
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3.4 Results and Discussion 
For the primary screening of 600,000 recombinant bacteriophages of the 
common carp genomic library on twelve plates with the Rsa I fragment of the 
common carp of IGF-I cDNA probe, we initially identified 14 positive signals after 
autoradiography, as shown in Fig. 3.3. Jn the plaque purification steps, ten plaque-
purified clones with positive signals were picked and named as P1 to P10 as shown in 
Fig. 3.4. 
Lti order to release the inserts from the phages, Xba I was used because this 
restriction enzyme cut the restriction sites at the multiple cloning site ofthe Lambda 
Fix n vector flanking the 5, end and 3，end of the genomic insert. The long arm and 
short arm of the phage vector were released as 22 kb and 9 kb DNA fragments 
respectively. The inserts of the 10 plaque-purified clones were released as several Xba 
I cut fragments. Double restriction-enzyme digestion, using either Eco RI or Hind HI 
restriction enzyme in combination with Xba I restriction enzyme, were also used to 
characterize these 10 clones (Fig. 3.5 and 3.6). Then, Southem blot analysis was 
carried out to identify the released fragments. The probes used were: (1) 5'-flanking 
region of the common carp IGF-I gene (clone IGFlP); (2) Rsa I fragment of common 
carp IGF-I cDNA (which contains the B, C, A and D domains coding for the mature 
IGF-I peptide); (3) Xho H) fragment of common carp IGF-I cDNA (which contains the 
3'-UTR of the IGF-I gene) (Fig. 3.5 and 3.6) According to the difference in restriction 
pattern, there are mainly two types of clones. One type of clones such as P1, P4, P7 
and P8 with similar restriction pattern, and another type of clones such as P2, P3, P5 
and P6 with different pattern. From these preliminary results, we found that only clone 
P1 could hybridize to the three probes used in Southem blot analysis and other clones 












Fig. 3.3 An autoradiograph showing a positive signal on one of the filter 
liftsfrom a primary screening of common carp genomic library using common carp 
IGF-I cDNA conserved region, Rsa I fragment (which contains the B, C, A and D 
domains coding for mature IGF-I peptide). The arrow point to the position of one of 
the positive signal, temporary labeled as #11. 
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~im： 
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Fig. 3.4 An autoradiograph showing the positive signals from one of the nylon 




















































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































contain the entire gene of common carp IGF-I and the insert size is about 13 kb. Our 
further characterization was then focused on this clone. The diagrammatic representation 
of the rdative positions of the insert from genomic clones as compared with the clone P1 
was shown in Fig. 3.7. All of them were partial clones of different parts of the IGF-I 
gene, except P6, as compared with the clone P1. The restriction pattem of the clone P6 
was found to be different from all the other clones. However, it binds to the common 
carp conserved IGF-I cDNA probe and specific E-domain probe. Thus, this clone may be 
a subtype of the IGF-I gene. To fmd out the answer, nucleotide sequence determination 
may be carried out for this clone, especially the fragments hybridized with the specific 
E-domain probe in the Southem blot analysis. 
To understand the structure of IGF-I gene in common carp, clone P1 was 
subjected to restriction-enzyme mapping using enzymes as described in the Section 
3.3.10. Fig. 3.8 shows the DNA gel and Southem analysis of the clone P1 after 
restriction enzyme digestion. The map of carp IGF-I genomic clone P1 is shown in Fig. 
3.9. The Hin& m fragments (2.7, 1.1，0.9 and 0.8 kb) were subcloned into pUC 18 
vector, except for the 5.5 kb. 
To confirm that clone P1 contains the whole coding region of IGF-I gene. PCR 
using IGF-I specific primers was performed. Fig. 3.10 shows the PCR products formed 
using the IGF-I 5，and IGF-I 3，reverse primer. The template of the positive control was 
the common carp genomic DNA. A sharp band of � 1 1 kb was amplified from the clone 
P1 so clone P1 probably contained the entire IGF-I gene. However, a smaller (-10 kb) 
DNA fragment was amplified using common carp genomic DNA as template, probably 
because different strains of common carp was used. The common carp used for genomic 
DNA preparation was obtained from local market but the library was obtained from 
Stratagene, La Jolla, using carp from USA. Southem blot study of the IGF-I specific 
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— ~ ~ ~ ~ — ^ ~ ~ - ~ ~ ~ — — ~ — " - — ^ ^ ^ ^ ~ " P1 
• « ~ ~ — ~ « ~ — ~ « ~ ~ ~ ~ ~ P2 
" ~ " ~ " « " ^ ~ ~ " " P3/P7 
— — — ^ — P4 
" ~ — ~ « ~ ~ ~ - ^ ~ ~ ~ ~ — — ~ " P5yT10 
_ ^ _ _ _ _ ^ _ _ _ _ _ _ _ i _ _ _ _ _ P8/P9 
0 1 2 3 4 5 6 7 8 9 10 11 12 13 14kb 
^ IG1 ^ IG3 <«_ IG5 — IG9 — IG7 
— I G 2 — IG4 _> IG6 — IG10 — IG8 
1 3 4 5 
^ ^ 
5’ P^e B C A D E 3， 
Fig. 3.7 Diagrammatic representation of the relative positions of the inserts from 
clones P1, P2, P3, P4, P5, P7, P8, P9 & P10. The solid lines shown above the scale bar 
represent the relative positions of the clones. Labeled arrows represent the relative 
position and 5，to 3，direction of the primers used in Takara PCR and DNA sequencing. 












































































































































































































































































































































































































































































































X E K X E K X X 
K K 
1 r ，f y f 1 r ’ r 去 去 ，f 
_i Common Carp IGF-I Gene ±  
0 1 2 3 4 5 6 7 8 9 10 11 12 13 kb 
Fig. 3. 9 Map of common carp IGF-I gene. Open box represents the phage clone 
P1 covering 13.5 kb genomic region. The restriction enzyme sites shown are E, Eco 
RI; Yi,Kpn I; X,Xba 1. 
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Lane 1 ~ lkb marker 
Lane 2 - Clone P1 + Primers 15 and 13 
Lane 3 - Clone P1 + Primer 15 
Lane 4 - Clone P1 + Primer 13 
Lane 5 - Water + Primers 15 and 13 
Lane 6 -- Common carp genomic DNA + Primers 15 and 13 
Lane 7 -- Common carp genomic DNA + Primer 15 
Lane 8 -- Common carp genomic DNA + Primer 13 
^ ^ ^ ^ ^ ^ ^ ^ ^ ^ ^ ^ ^ ^ 8 
謹 ^ ^^ ^^ HH • # 
^ ^ 3 ^ ^ ^ ^ ^ ^ ^ ^ H I ^ ^ ^ H :::;^^__:謹 ..:.^^1:::1:丨:|『 
^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^H ^^^JB^i^^ 
^ 9 | | P ^ ^ | ^ ^ H ^ ^ | m^^ 
6kb ~ ^ ^ ^ ^ i ^ i i i i i i ^ ^ ^ i m ^ m ^ ^ ^ ^ 
HBHIHHHI _ 禱 m m m _ y m u t 
n ^ m i H H i i i ^ 
3kb - ^ ^ g u | ^ ^ ^ H ^ ^ j W ^ 
Fig. 3.10 Left panel: The DNA gel (after EtBr staining) showing the PCR 
products of IGF-I specific PCR using IGF-I 5' primer (15) and IGF-I 3’ reverse primer 
(13). The template used is either clone P1 and common carp genomic DNA. Right 
panel: The Southern blot analysis ofthe PCR products using the Rsa I fragment of the 
cloned common carp IGF-I Ea2 cDNA as a probe for hybridization. 
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PCR products using Rsa I fragment of common carp IGF-I Ea2 cDNA as a probe is 
also shown in Fig. 3.10. 
The chum sahnon IGF-I gene contains three introns (Kavsan et aL, 1993). 
Based on the structure of chum salmon IGF-I gene and the sequence of the common 
carp IGF-I cDNA, three pairs of primers were designed to amplify the introns from the 
clone P1 using PCR QFig. 3.11). Intron I was found to be 1.2 kb in size, intron H was 
found to be about 6.5 kb in size and intron HI was found to be about 3.2 kb in size. 
We also found that the size of intron HI using common carp genomic DNA as 
template is about 1.3 kb less than that obtained using clone P1 as template, confirming 
the strains difference between local carps and American carp. Then, the introns were 
cloned into the pCR® 2.1 vector and the introny'exon junctions were sequenced. Litron 
I and ni were successfully sequenced. However, after nucleotide sequence 
determination, we found that intron EI amplified contains an additional intron. 
Therefore, the common carp IGF-I gene contains five exons, interrupted by four 
introns. This structural organization was found to be similar to the second non-alleic 
IGF-I gene of chum sahnon which contains one additional intron in the E-peptide 
region (Kavsan et al., 1994). Fig. 3.12 summarizes the intron-exon organization of the 
common carp IGF-I gene. 
However, we only determined the introny'exon junctions of the cloned IGF-I 
gene. To understand the entire structure and confirm whether the clone belong to IGF-
I Ea2 subtype, nucleotide sequence determination may be carried out for the 
subcloned Hind HI fragments. 
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Lane 1 - Clone P1 + Primers IG2 and IG3 
Lane 2 - Clone P1 + Primers IG4 and IG5 
Lane 3 -- Clone P1 + Primers IG6 and IG7 
Lane 4 -- Water + Primers IG2 and IG3 
Lane 5 -- Water + Primers IG4 and IG5 
Lane 6 ~ Water + Primers IG6 and IG7 
Lane 7 -- Common carp genomic DNA + Primers IG2 and IG3 
Lane 8 -- Common carp genomic DNA + Primers IG4 and IG5 
Lane 9 — Common carp genomic DNA + Primers IG6 and IG7 
Lane 10 — 1 kb marker 
1 2 3 4 5 6 7 8 9 10 
^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^H^^^^^^^ H^^^^^^^^^^^^^^^^^^9 
^^^^^^H^^^^^^^^^^^^^^^^^^^^^^^^^^^^ 
^ ^ ^ ^ m i m ^ ^ Q ^ 6kb 
^^^^^^^^^^^^^^K^^^^^S^K^^^^^^^^^^^^^^ 
I^B^2kb 
H ^ b 
Fig. 3.11 The DNA gel (after EtBr staining) showing the PCR products from the 
amplification of introns using IGF-I gene specific primers designed from the common 
carp IGF-I Ea2 cDNA. The template used is either clone P1 and common carp 
genomic DNA. 
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Exon Exon 5' Splice donor Litron 3' Splice acceptor 
size size 
^e ^  
1 �lk GTCTTTAAGgtaac... 1.2 ..tgcagTGTACCATG...exon 2 
ValPheLys CysThrMet 
2 160 TTTTATTTCAgtaag. . 6.5 . . aacagGCAAACCAACA. exon 3 
PheTyrPheS erLysProThr 
3 182 ACAGCAAAGgtgtg. . . 0.7 . .tacagAAACCTTTA. . .exon 4 
ThrAlaLys LysProLeu 
4 36 To be determined 2.5 ..atcagGAGGTTCAT...exon 5 
GluValHis 
5 � lk ;; - ;;; 
Fig. 3.12 Mron-exon organization of the common carp IGF-I gene. 
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CHAPTER 4 RNA ASSAY USLVG REVERSE TRANSCREPTION-
POLYMERASE CHAIN REACTION 
4.1 Introduction 
The basic mechanism of GH-IGF axis is also shown to be operative but in a 
different mamer in teleost. For example, both IGF-I and GH were found to be related 
to somatic growth in fish (Skyrud et al., 1989; Gray and Kelly, 1991; McCormick et 
al., 1992). ln rainbow trout, however, both IGF-I and IGF-E also show GH-
dependence (Shamblott et al., 1995). 
RNase protection assay was used to study the effect of bovine GH on the 
levels of IGF-I and IGF-H mRNA in juvenile rainbow trout {Oncorhynchus mykiss) 
(Shamblott et al., 1995). A single i.p. injection of bovine GH at a dose of 10 ugy'g 
body weight resulted in a significant increase in IGF-I and IGF-H mRNA levels in 
liver when compared with control. Li another experiment, homologous 
radioimmunoassay was also used to study the effect of salmon GH on the level of 
plasma IGF-I in rainbow trout {Oncorhynchus mykiss) (Moriyama, 1995). A single i.p. 
injection of sahnon GH at a dose of 0.1 or 1.0 ug/g body weight resulted in a 
significant increase in plasma IGF-I level in a dose-dependent manner. 
Since both IGF-I and IGF-H mRNA are found in adult and juvenile fish 
tissues, it was suggested that both IGF-I and IGF-H may have somatic growth effects 
in both juvenile and adult trout (Shamblott and Chen, 1993). Whether this 
phenomenon is universally true for other fish species remains to be established. 
Amplified PCR products increase exponentially with reaction cycle, therefore, 
even a slight increase in the number of initial templates will drastically increase the 
efficiency of PCR. Reverse transcriptase (RT), capable of generating multiple copies 
of cDNA from mRNA prior to PCR, greatly increase the amplification products and 
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enhances sensitivity and specificity of analysis. It also provides an opportunity to 
study multiple gene expression (Liu et al., 1997). 
Using RT-PCR, it was found that IGF-I Ea2 is the predominantly expressed 
form ofIGF in the liver of adult common carp (Liang et al., 1996). t i this project, by 
visualizing the gene products after ethidium bromide staining, we used a 
semiquantitative RT-PCR method to investigate the effect of fish GH on the level of 
hepatic IGF-I mRNA in common carp. The total RNA of liver was prepared and RT-
PCR using IGF-I specific primers was performed. 
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4.2 Materials 
Growth hormone (Section 4.3.1) 
The fish growth hormone used in the present study is the recombinant black bream 
GH obtained commerically from GroPep, Australia. 
Saline (Section 4.3.1) 
0.9%NaCl 
Sterilized by autoclaving for 20 min at 151b/sq. in. liquid cycle. 
DEPC-H2O (Section 4.3.2, 4.3.3 and 4.4.4) 
Add diethyl pyrocarbonate (DEPC) to 0.1% in ddH2O and stir overnight, then sterilize 
the solution by autoclaving for 20 min at 151b/sq. in. liquid cycle. 
5X formaldehyde gel-running buffer (Section 4.3.3) 
0.1MMOPS,pH7.0 
40mM sodium acetate 
5mMEDTA 
Formaldehyde geMoading buffer (Section 4.3.3) 
50% glycerol 
lmMEDTA 
0.25% bromophenol blue 
0.25 % xylene cyanol FF 
20X SSC (Section 4.3.4) 
175.3gNaCl 
88.2g sodium citrate 
Add ddH2O to a fmal volume 1 liter, adjust pH to 7.0 with 10N NaOH, treated with 
diethyl pyrocarbonate (DEPC) (0.1% in water) and stir overnight, then sterilize the 
buffer by autoclaving for 20 min at 151b/sq. in. liquid cycle. 
10% SDS (Section 4.3.4) 
100g SDS 
Add ddH2O to 1 liter, heat to 6S^C, adjust pH to 7.2. 
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4.3 Methods 
4.3.1 Adminstration ofHormones 
Two injection time courses were used in common carp IGF-I gene expression 
studies. The sbGH (Section 4.2)was dissolved in saline (Section 4.2) 
4.3.1.1 Injection Time Course 1 
Groups (10 fish per group) of juvenile common carp were transferred to 
smaller indoor static tanks (lOL) with aerated fi:esh water under natural temperature 
(~15°C) and photoperiod for 10 days prior to the experiment. They were kept on daily 
feeding regimen during the experiment. The fish received i.p. injections of 1000，100 
and 0 (saline control) ng sbGH in a volume of 10 ]xVg total wet body weight every 
other day between 9 am and 12 pm for a total of 4 injections (in a span of 7 days). The 
fish were killed 24 hr after the last injection. Liver was collected and pooled together 
from each group and immediately transferred to liquid nitrogen. The tissues was then 
stored at -70 °C until RNA extraction. The expression of IGF-I mRNA was then 
studied using Northern blot analysis of poly A+ mRNA with a common carp IGF-I 
probe (conserved region). 
4.3.1.2 Injection Time Course 2 
Groups (3 fish per group) of junvenile common carp were transferred to 
smaller indoor static tanks (lOL) with aerated fresh water under natural temperature 
(�15°C) and photoperiod for 10 days prior to the experiment. Fish were not fed for 24 
hr before fGH adminstration. The fish received i.p. injections of 1000，100 and 0 
(saline control) ng sbGH in a volume of 10 p,Vg total wet body weight every twelve hr 
for a total of 2 injections (within 1 day). The fish were killed 12 hr after the last 
86 
injection. Liver was collected from each individual and immediately transferred to 
liquid nitrogen. The tissues was then stored at -70 °C until RNA extraction. The 
expressipn ofIGF-I mRNA was then studied using RT-PCR. 
4.3.2 Total RNA Extraction 
Glassware after autoclaved was baked at 150^C ovemight. Plasticware was 
filled with 0.1% DEPC (Section 4.2) after stirring ovemight and then autoclaved. 
Electrophoresis tanks used for electrophoresis of RNA were cleaned with detergent, 
rinsed in water and then soaked with a solution of 3% H2O2. After incubated at room 
temperature ovemignt, the tanks were rinsed with DEPC treated water. Gloves were 
wom at all times during the experiment because hands of the investigator were 
potentially major sources of RNase contamination. 
4.3.2.1 Rapid RNA Isolation 
TRI REAGENT® (Molecular Research Centre, Lic.) was used to extract the 
total RNA from common carp liver. For one hundred mg tissues, 1 ml TRI 
REAGENT® was used. The tissues was then homogenized with a tissue grinder. The 
mixture was stored on ice for 5 min. Then, 0.1 ml bromochloropropane (BCP) was 
added and mixed vigorously. The mixture was then cooled on ice for 10 min followed 
by centrifugation at 4^C and 14,000 rpm for 15 min. The upper aqueous phase 
containing the RNA was transferred to a fresh tube, whereas the DNA and proteins 
were in the interphase and lower organic phase. Half a ml of 100% isopropanol was 
added to the aqueous phase to precipitate the RNA. The sample was stored at -20^C 
ovemight followed by centrifugation for 15 min at 14,000g at 4^C. The supernatant 
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was discarded and the pellet was washed by 1 ml 75% ethanol. It was then centrifuged 
for 5 min at 14,000g and the supernatant was discarded. The pellet was dried in 
vacuum for 5 min and then dissolved in 50 ^1 DEPC-treated water. The absorbance of 
the RNA at 260 nm and 280nm was measured. The RNA was then stored in -70^C. 
4.3.3 Electrophoresis of RNA in Agarose Gel Containing Formaldehyde 
The isolated total RNA was electrophoresed (Sambrook et al., 1989) in order 
to check the integrity of the RNA. An 1.2 % agarose gel was prepared in 
formaldehyde gel-running buffer (Section 4.2) by melting an appropriate amount of 
agarose in water, cooling it to 60^C, and formaldehyde was added to give a final 
concentrations 2.2M. The gel was casted and allowed to set for at least 30 min inside a 
fumehood. Then the samples were prepared by mixing the following components in a 
microfuge tube: 5 ^1 ofRNA (10 i^g), 2.0 i^l of 5X formaldehyde gel-rumiing buffer, 
3 i^l of formaldehyde，10|il of formamide and ljal of EtBr (l|Lig/^l). The samples were 
incubated for 15 min at 68^C, and then quick-chilled on ice for 5 min. Two fo,l of 
formaldehyde gel-loading buffer (Section 4.2) was added before loading. As 
formaldehyde vapors were toxic, solutions containing formaldehyde were prepared in 
a chemical hood, and electrophoresis tanks containing formaldehyde solution were 
kept covered whenever possible. The gel was immersed in IX formaldehyde gel-
running buffer. The RNA samples were loaded into the wells of the gel. 
Electrophoresis was carried out at 70V constant voltage. The RNA in the gel was 
visualized and photographed by UV illumination. 
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4.3.4 Rapid Isolation of PolyA+ mRNA from Total RNA 
The pooled total RNA samples obtained from injection time course 1 (Section 
4.3.1.1) were used as starting materials for underwent polyA+ mRNA isolation using 
PolyAtract mRNA Isolation System (Promega). One mg of total RNA to a fmal 
volume of 500 ^1 in DEPC-H2O (Section 4.2) was heat denatured at 65�C for 10 min. 
Six ^1 ofthe Biotinylated-Oligo(dT) probe and 90 ^1 of20X SSC (Section 4.2) were 
added to the RNA. The mixture was mixed gently and incubated at room temperature 
until completely cooled to allow the annealing of Biotinylated-Oligo(dT) probe 
(provided by the kit) to the polyA+mRNA. Then, the entire contents of the annealing 
reaction was added to the tube containing the washed Streptavidin-Paramagnetic 
Particles (SA-PMPs) ^)rovided by the kit) and incubated at 37°C with shaking. The 
SA-PMPs containing the annealed oligo(dT)-mRNA hybrid were captured using the 
Magnetic Stand provided by the kit. Then, the particles were washed three times with 
0.6X SSC (Section 4.2) and captured again with the Magnetic Stand. The mRNA was 
eluted by resuspending in 250 i^l ofpreheated DEPC-H2O (65°C) and stored at -70°C. 
Ten |ig of polyA+ mRNA was fractionated using the method mentioned in 
Section 4.3.3. Capillary transfer ofRNA to nylon membrane (Amersham) in 20X SSC 
(section 4.2) were carried as described in Section 3.3.8 without the denaturing step 
and the aDcaline transfer buffer was replaced with 20X SSC (Section 4.2). Northern 
analysis using the carp Rsa I fragment of IGF-I cDNA and zebrafish P_actin (positive 
control, Chan, unpublished data) probes was performed as described in Section 3.3.4. 
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4.3.5 IGF-I Specific RT-PCR 
The Titan™ One Tube RT-PCR System (Boehringer Mannheim) and the 
Perkin Ehner GeneAmp 9600 thermocycler were employed to determine the 
expression level ofIGF-I in common carp after sbGH i.p. injection (samples obtained 
from injection time course 2, Section 4.3.1.2). The cDNA reaction as well as the PCR 
were performed with an optimized buffer and enzyme without requirement for 
addition of reagents between cDNA synthesis and PCR. The one step reaction system 
T*K>f 
system uses AMV for first strand synthesis and the Expand High Fidelity enzyme 
blend, which consist of Taq DNA polymerase and Pwo DNA polymerase, for the 
polymerase reaction. The cycle profile is given as below: 
IX 50�C 30min 
IX 94�C 2min 
10X 94�C 10 s 
55°C 30 s 
68°C 45 s 
15X 94�C 10 s 
55°C 30 s 
68°C 45 s 
+ cycle elongation of 20s for each cycle 
IX 68°C 7min 
]n each reaction, 1 ^ ig of total RNA, 1 ^ 1 of the enzyme mixture，and 20 pmole of each 
primer were used in a reaction of 50 |il. The position of the primer could be seen in 
Fig. 3.1. The nucleotide sequences of primer sets for carp IGF-I and actin control are: 
Carp IGF-I, 
IGF-5，primer 5'GATGTCTAGCGGACATTTCTTC3 ‘ and 




Actin-3，reverse primer 5 'ATCCACATCTGCTGGAAGGT3 ’ 
Ten |il of PCR product were fractionated in a 2% (w/v) IX TAE agarose gel. The 
intensity of each band was determined using a PC version ofLnageQuaNT (Molecular 
Dynamics) software in a laser densitometer (Personal Densitometer SI™, Molecular 
Dynamics). 
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4.4 Results and Discussion 
For the injection time course 1，the liver samples in each group following 
intraperitoneal injections of sbGH at doses of either 100 or 1,000 ng/g were pooled 
and total RNA was then purified (Fig. 4.1). Changes in hepatic IGF-I mRNA are 
shown in Fig. 4.2. Ten ^g of polyA+ mRNA were isolated from the total RNA and 
fi:actionated using electrophoresis. Northern blot analysis was used to determine the 
expression level of hepatic IGF-I mRNA. Three bands were identified. Therefore, it 
may have three mRNA transcripts for IGF-I in the liver of common carp. However, 
there was no significant changes in the expression levels of hepatic IGF-I mRNA in 
GH-treated and saline control fish as indicated by the intensities of the bands. Li 
rainbow trout {Oncorhychus mykiss), after intraperitoneal injection of sahnon GH at 
doses of 0.1 or 1.0 ^g/g body weight, plasma GH levels increased to a maximun after 
6 hr and declined rapidly thereafter OVLoriyama, 1995). Therefore, the clearance rate 
for GH in common carp may also be very fast and the effect of GH on IGF-I 
expression was diminished during the long chronic injection time courses. 
To improve the experimental design, we tumed to use a short and acute 
injection time course to study the expression ofhepatic IGF-I. Forty |ug of total RNA 
was fractionated and Northern blot analysis was carried out to measured the hepatic 
IGF-I mRNA level (Fig. 4.3). However, there was no obvious band observed after 
autoradiography as compared to the actin positive control. Therefore, the expression 
level of hepatic IGF-I may be so low that could not be detected using Northern blot 
analysis of the liver total RNA and RT-PCR was performed to examine the expression 
ofIGF-I mRNA. 
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Lane 1 -- saline control 
Lane 2 ~ 100 ng sbGH per g total body wet weight 
Lane 3 _- 1,000 ng sbGH per g total body wet weight 
Lane 4 - RNA size marker 
1 2 3 4 
mm 
| ^ m m | J J | | | ^ J ^~~~ 7.46 kb 
28S - r _ _ | 1 _ _ _ " _ _ " r ^ ^ J — 4.40kb 
18S W ^ • " • 置 零 | | | | | — 2.37kb 
• X m 产 m ^ t ^ m 一 l-35kb | | | j | ^ 
U m H ^ J J J I 4 _ 0.24 kb 
5s — • • w _ m i i 曜 
Fig. 4.1 The RNA gel showing the integrity of the pooled RNA samples (10 
^g) obtained from injection time course 1 (Section 4.3.1.1). 
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Lane 1 - saline control 
Lane 2 ~ 100 ng sbGH per g total body wet weight 
Lane 3 - 1,000 ng sbGH per g total body wet weight 
1 2 3 
4 H H ^ < 4 ^ 4 M M > s 
^ ~ 7.46kb 
.一 ‘ ^~~ 4.40kb 
^^^^^k j|^^^ d M ^ ^ 
'^^^^^^ P^^ ^^ |P^  ^^PPPPP|P^  
R I b &H^ H A l k f t ^ 2.37 kb 
a pro e — 冒 霸 》 胃 — i . 3 5 k b 
^^¾> ^^ft ^wA ^ ^ P ^ ^ ^^m 
< ~ 0.24 kb 
^¾!^ ¾¾¾:::¾!^ :¾;!¾ 
Actin probe ^ A ^ ^ | ^ K 
*^^^ 5^*W^  ^WHP 
Fig. 4.2 Northern blot analysis of the pooled polyA+ mRNA (10 |ug) obtained 
from injection time course 1 (Section 4.3.1.1). The probes used were: (1) Rsa I 
fragment of common carp IGF-I cDNA (which c6ntains the B, C, A and D domains 
coding for mature IGF-I peptide); (2) zebraflsh actin probe (control). 
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Lane 1, 2 and 3 ~ saline control 
Lane 4, 5 and 6 -一 100 ng sbGH per g total body wet weight 
Lane 7，8 and 9 — 1,000 ng sbGH per g total body wet weight 
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Actin probe ^ ^ ^ ^ j^^mMM. 
.1^^^^^Ri 
Fig. 4.3 RNA gel and Northern analysis of the individual total RNA samples 
(40 i^g) obtained from injection time course 2 (Section 4.3.1.2). The probes used 
were: (1) Rsa I fragment of common carp IGF-I cDNA (which contains the B, C, A 
and D domains coding for mature IGF-I peptide); (2) zebrafish actin probe (control). 
Lane M was the RNA marker. 
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After RT-PCR, using 1 |ig oftotal RNA as template, the PCR products were 
fractionated by electrophoresis. (Fig. 4.4). The IGF-I mRNA was amplified as a 480 
bp DNA fragment and the intensity of each band was analyzed using a densitometer. 
Fig. 4.5 shows the relative levels ofhepatic IGF-I mRNA normalized by actin control. 
The level ofhepatic IGF-I mRNA was elevated (P<0.09) after injection with lOOng/g 
fGH as compared to saline control. However, the level of hepatic IGF-I mRNA 
following i.p. injection ofl,000 ng/g sbGH was similar to the saline control. 
]n rainbow trout, the levels ofhepatic IGF-I mRNA increased significantly ( � 2 
to 3 fold) in response to i.p. injection of 10 |ig bovine GH at 6 and 12 hr (Shamblott et 
al., 1995). Li Sparus liver, Northern analysis revealed that the IGF-I mRNA level 
increased about fivefold after i.p. injection of human GH at a dose of 1.0 |ig/g body 
weight (Duguay et aL, 1996). After i.p. injection of sabnon GH at doses of 0.1 or 1.0 
|ig/g body weight to rainbow trout, plasma IGF-I levels were elevated after 12 hr, 
reaching maximum ( � 2 to 3 fold) at 24 hr and (after the higher dose of GH) remaining 
at 78 hr after GH injection. The effect of GH on plasma IGF-I level was dose-
dependent(Moriyama, 1995). 
From the above studies, GH treatment can significantly elevated the hepatic 
IGF-I mRNA level. However, in the present study, we found that the common carp 
hepatic IGF-I mRNA level (after the lower dose sbGH) was increased by only one-
third the saline controls but no significant change was detected in the higher dose of 
GH. Therefore, the response of common carp to GH was found to be different from 
other teleosts. To confirm the results obtained in present study, other quantitative 
methods, such as competitive RT-PCR, Northern blot analysis using PolyA+ mRNA 
and Ribonuclease protection assay, may be used to study the time course in vivo. 
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Lane 1，2 and 3 - saline control 
Lane 4，5 and 6 — 100 ng sbGH per g total body wet weight 
Lane 7，8 and 9 - 1,000 ng sbGH per g total body wet weight 
Lane 10 — negative control 
M 1 2 3 4 5 6 7 8 9 10 M 
^ ^ ^ ^ m ^ ^ ^ ^ ^ H B 
^ ^ ^ ^ ^ ^ ^ ^ n 
^ ^ ^ ^ ^ ^ ^ ^ ^ ^ ^ ^ ^ B 
K^^^^^^^^^^^^^^^^^^^^^^^^^^^^^S s^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^S 
9 ^ ^ ^ ^ ^ ^ ^ ^ ^ ^ ^ P . ~ _ 600bp 
IGF-I ^BB^^^^^^^^^^^^^^^^^^^^^^^^KS 
^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^H 
^ ^ ^ ^ ^ ^ ^ ^ ^ ^ ^ ^ ^ ^ ^ ^ ^ ^ ^ ^ ^ ^ H 
^ ^ | ^ ^ H | | ^ ^ ^ ^ ^ ^ ^ ^ ^ H ^ _ bp 
Actin ^ C C C C L d C H 
Fig. 4.4 Agarose gel electrophoresis of RT-PCR products using total RNA 
obtained from time course 2 (Section 4.3.1.2). The gel was stained with EtBr after 
electrophoresis. Upper panel shows the result of using the common carp IGF-I specific 
primers. Lower panel shows the result of using the p-actin primers (control). Lane M 
was the 100 bp marker. 
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Fig. 4.5 Relative levels of hepatic IGF-I mRNA in control and GH-treated 
common carp as measured by RT-PCR. Groups of fish (n = 3) received 100 ng and 
1,000 ng per g total body wet weight of sbGH or saline vehicle. Each bar with vertical 
line represents mean 士 S.D.. 
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In vitro assay using cultured cells would also be useful to study if GH induces IGF-I in 
hepatocytes. 
Although a feature of the RT-PCR is that it can provide high sensitivity for the 
detection and amplification of specific nucleic acid sequences, it also presents a 
substantial problem in attempting to apply to quantitative applications. The impact on 
the absolute amount of amplified product produced by experimental variations such as 
pipetting error, initiation of misprimed amplifications, variations in amplification 
efficiency due to naturally occurring or introduced inhibitors, subtle differences in 
reagent purity or reaction composition, differences in amplification kinetics related to 
the number of initation events (particular for low-copy-number specimens), and even 
minor reaction-to-reaction differences in reaction temperature control for thermal 
cyclers are all exaggerated by exponential amplification. The net result is that, because 
of these factors, a consistent relationship between the amount of input target template 
and absolute amount of amplified product is very difficult to obtain (Krieg, 1996). 
To develop approaches to harness the power of the PCR for quantitative 
applications, the majority of investigators have attempted to provide some form of 
internal control for the variability that can be expected. 
ln my present study, IGF-I was coamplified along with actin (heterologous 
sequence) expected to be present at a relatively constant level as an endogenous 
component of the sample using distinct primers. However, the use of a heterologous 
template as an internal control provides only a gross control for overall efficiency of 
amplification, such as revealing effects that might be expected if a specimen contained 
a substance that inhibited the PCR. Other inherent differences related to the use of a 
heterologous sequence, such as differences in template abundance and in primer 
binding efficiencies for the two templates, render this approach less than ideal. 
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Recently, another approach of RT-PCR, known as competitive RT-PCR, is 
used. The target template is coamplified along with increasing known amounts of a 
closely matched, usually synthetic, template having the same primer binding 
sequences, whose derived amplified product can be discriminated and differentially 
quantified relative to the product from the target template. This approach provides 
more stringent internal control and the multipoint titration effectively provides the 
equivalent of multiple confirmatory reactions for each sample, minimizing the 
potential confounding effects of aberrant reactions on accurate quantitation. Li 
addition, extrapolation onto a tiration plot to determine the tiration equivalence point 
(where the amount of product derived from the target template is equal to the amount 
of product derived from internal standard) may provide improved accuracy compared 
to calculations based on single point ratio of the two products, particularly if the 
absolute amounts of the two products for a particular reaction differ widely and if the 
reactions are carried to the postexponential phase of amplification. The obvious 
disadvantage of this multipoint titration approach is the requirement to perform 
multiple reactions, with corresponding increases in cost and labor-intensiveness 
OKrieg, 1996). 
Other more sensitive and specific methods such as Northern blot analysis of 
polyA+ mRNA and ribonuclease protection assay may be used to quantify the amounts 
of mRNA (Shamblott and Chen, 1993; Duguay et cd., 1996). The major disadvantage 
of the above methods is the use of radioactive isotope. 
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CHAPTER 5 SEARCH FOR IGF-H GENE WITH GENOMIC 
SOUTHERN BLOT ANALYSIS 
5.1 Introduction 
Both IGF-I and IGF-E cDNA sequences were identified in seabream and 
rainbow trout (Shamblott and Chen, 1992; Duguay et al” 1996). Recently, another 
fish IGF-n cDNA was isolated from tilapia brain cDNA library (Chen et al, 1997). 
The alignment of seabream and rainbow trout preproIGF-E amino acid sequences 
revealed that this hormone has also been well conserved among the teleosts The 
overall amino acid sequence similarity was 84 % and there were only three amino acid 
differences, all located in the C-domain, between seabream and rainbow trout IGF-H. 
Even the nucleotide sequence identity had 85% match. The E-domains were also well 
conserved with 80% similarity (78/98 amino acids). The amino acid sequences of E-
domians in human and fish proIGF-H only show 37% identity. 
To identify the presence of IGF-I and -E in common carp, we screened a 
genomic library for IGF genes in the genome of common carp but only identified ten 
IGF-I clones. Therefore, the presence of other IGF subtypes might not be detectable if 
the common carp IGF-I cDNA (conserved B, C, A and D domain of mature peptide) 
probe used in the genomic library screening could only identify IGF-I sequences. 
Li rainbow trout, the absence of pattem similarity in genomic Southern blot 
analysis suggested that rainbow trout IGF-I and IGF-H are encoded by two different 
genes (Shamblott and Chen, 1992). Therefore, the nucleotide sequences of IGF-I and 
IGF-n in common carp may be quite different. To identify if IGF-H is in the genome 
of common carp, we used trout IGF-H cDNA (more related to the sequence of 
common carp IGF-H if present) as a probe for Southern blot analysis of common carp 
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lOmgy^ ml Proteinase K ^Boehringer Marmheim) 
10M Ammonium acetate (Section 5.3.1) 
770g ammonium acetate 
Add ddH2O to 1 liter, sterilize by filtration. 
50X Tris borate (TBE) (Section 5.3.3) 
54g Tris base 
27.5g boric acid 
20ml0.5MEDTA, pH8.0 
Add ddH2O to 1 liter. 
6X Loading buffer for agarose gel electrophoresis (Section 5.3.3 and 5.3.4) 
0.25% bromophenol blue 
0.25% xylene cyanol FF 
40% (w/v) sucrose in water 
50X Tris acetate (TAE) (Section 5.3.4) 
242g Tris base 
57.1 ml glacial acetic acid 
100 ml 0.5M EDTA, pH8.0 
Add ddH2O to 1 liter. 
20X SSC (Section 5.3.5) 
175.3gNaCl 
88.2g sodium citrate 
Add ddH2O to 1 liter, adjust pH to 7.0 with NaOH, sterilize the buffer by autoclaving 
for 20 min at 1511b/sq. in liquid cycle 
10% SDS (Section 5.3.5) 
lOOgSDS 
Add ddH2O to 1 liter, heat to 68°C, adjust pH to 7.2 
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5.3 Methods 
5.3.1 Preparation of Genomic DNA from Carp Testis 
Procedures as described in Section 2.3.1. 
5.3.2 Restriction Enzyme Digestion of Genomic DNA 
Genomic DNA samples were digested with restriction enzymes. About 20 i^g 
of genomic DNA was digested with excess amount of restriction enzymes. Bam HI, 
Eco RI, Hind HI and Xba I were used to digest the genomic DNA in 100 ^1 of the 
corresponding buffer. The reaction mixtures were incubated at 37°C ovemight. The 
digested DNA samples were ethanol precipitated and further dissolved in 30 ^1 
sterilized water. 
5.3.3 Southern Blotting of the Digested Genomic DNA 
Thirty p,l of the digested DNA samples were fractionated in a 0.9% agarose gel 
in TBE buffer (Section 5.2). The fi:actionated DNA was transferred to Hybond-N 
nylon membrane after EtBr staining as described in Section 3.3.8. 
5.3.4 Preparation of the Trout IGF-H Specific Probe 
The trout IGF-H cDNA clone was obtained fi:om Dr. Thomas T. Chen 
OJniversity of Maryland, Bethesda, U.S.A.). The clone was digested with Eco RI and 
Xho I restriction enzymes in an appropriate buffer, releasing the insert from the 
pBluescript SK vector. After 1.5% agarose gel electrophoresis in IX TAE buffer 
(Section 5.2), the DNA fragment was excised and purified using Gene Clean method 
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as described in Section 2.3.5. The Eco ^-Xho I fragment released contained the entire 
coding region for trout IGF-E. 
5.3.5 Genomic Southern Hybridization 
The zebrafish actin probe (Chan K.M. unpublished work) was used as positive 
control. The blot was hybidized with the IGF-H probe and then with the actin probe. 
The probes were labeled with 32p_dCXP using a Nick Translation kit (GibcoBRL) 
and purified by NucTrap® push columns (Stratagene) as described in Section 3.3.5. 
The blot was prehybridized at 65^C for 1 hr and then hybridized at 65^C for 2 hr in 
Rapid-hyb buffer (Amersham). After hybridization, the filter was first washed twice in 
2X SSC (Section 5.2) at room temperature for 15 min each, twice in 2X SSC, 0.1% 
SDS (Section 5.2) at 65^0 for 30 min each and fmally exposed to Kodak BIOMAX™ 
MR film at -70^C for 4 days between intensifying screens. 
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5.4 Results and Discussion 
Li common carp, genomic Southem blot analysis revealed that two gene 
fragments hybridized with the IGF-I Ea2 cDNA probe in the genomic DNA digested 
with Eco RI and Xba I，whereas Hind KI digested DNA showed three bands (Liang et 
al., unpublished data). The intron interrupting the exon 2 and 3 is approximately 10 kb 
in the chum salmon IGF-I gene (Kavsan et al., 1993), and might contain a site for 
Hind ni in the common carp IGF-I gene or IGF-H gene (Eco RI, Hind HI and Xba I 
restriction sites are not present in the cloned common carp IGF-I Ea2 cDNA, i.e. the 
exons). The result suggested that there are at least 2 IGF genes in the common carp 
genome. 
To identify the presence of both IGF-I and -E in the genome of common carp, 
we screened a genomic library using the IGF-I cDNA Rsa I fragment (containing the 
conserved B, C, A and D domains) for IGF genes. Presumably, the IGF-I conserved 
probe would be able to hybridize with both the IGF-I and IGF-H genes. After library 
screening, only IGF-I gene was identified but no IGF-H gene was found. The two Xba 
I fragments from the positive clones identified with sizes 7 kb and 4 kb are similar to 
the bands found in Southem blot analysis of the Xba I digested common carp genomic 
DNA using Rsa I fragment of the common carp IGF-I cDNA as a probe. These two 
Xba I fragments were found to be contiguously linked together and therefore they 
could be from the same gene but spilted by an intron that contains an Xba I site. For 
the three Hin& HI gene fragments found in the Southem blot analysis, they are also 
likely to be linked. 
Li rainbow trout, IGF-I was found to be only 43.3% nucleotide sequence 
identical and 60.9% amino acid similar to IGF-H (Shamblott and Chen, 1992). 
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Therefore, the common carp IGF-I probe used in library screening may only identify 
IGF-I but not IGF-n. 
Mammalian IGF-I and IGF-E are encoded by separate genes. Li rainbow trout, 
IGF-I and IGF-H are also encoded by two separate genes as indicated by the absence 
of pattem similarity in the genomic Southern blot analysis using either IGF-I or IGF-H 
probe (Shamblott and Chen, 1992). Therefore, the pattem of genomic Southern blot 
analysis for IGF-H may be different from IGF-I in common carp. 
Then, we used trout IGF-E cDNA as a probe (presumably more similar to carp 
IGF-H) for Southern analysis of common carp genomic DNA. After hybridization, no 
obvious bands were detected from the blot as compared to the positive control (Fig. 
5.1). The absence of pattem in the blot suggests that (1) the nucleotide sequence of 
common carp IGF-H may be very different from the trout IGF-H or other fish so that 
the probe used could not identify IGF-E in common carpIGF-H. It is not likely as the 
alignment of rainbow trout and seabream which revealed that this hormone is well 
conserved among teleosts. ； or (2) common carp may not have IGF-H in the genome; 
or (3) the experiment did not work (?). However, we repeated the experiment for a 
total of three times, only the rtlGF-H probe did not work but zebrafish actin probe can 
hybridize to the blots. Therefore, until now, only IGF-I gene but no IGF-H gene could 
















































































































































































































































CHAPTER 6 GENERAL DISCUSSION AND CONCLUSION 
.This thesis reports the use of common carp {Cyprinus carpid) as a tropical fish 
model to study the molecular biology of IGFs with a view to elucidate their gene 
structure and gene expression in response to GH administration. 
Cloning ofthe Common Carp IGF-I Promoter Region 
Li the present study, we reported the cloning of the 5，region of IGF-I gene 
from common carp using genomic PCR. This clone carries an inset of 840 bp 
encompassing the 5'-UTR and part of the signal peptide. This portion of the common 
carp IGF-I gene was highly homologous to the analogous regions of other IGF-I genes 
such as chicken and human (Rotwein et aL, 1986; Kajimoto and Rotwein, 1991) if a 
GAGA-like sequence, which is present in other IGF-I genes but absent in teleost IGF-I 
genes, is deleted. 
As in the chicken, human and rat IGF-I genes (Kajimoto and Rotwein, 1991)， 
no consensus TATA box or AT-rich region was present. These are the promoter 
elements required for the RNA polymerase to locate the start site in a relative fixed 
location. As a result, multiple start sites are used in the transcription of IGF-I 
(Kajimoto and Rotwein, 1991). Like chicken, human and rat, there is a TATA-like 
consensus sequence approximately 250 bp 5，upstream of the first methionine codon 
of the common carp IGF-I coding sequence. Li contrast, there is no CCAAT-like 
sequence. 
We are now in a position to analyze (1) the promoter activity of this DNA 
fragment, (2) determine the transcription start sites in the common carp IGF-I gene 
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and (3) determine the protein factors that interact with the carp IGF-I genes with or 
without stimulation by GH. 
Search for Multiplicity ofIGF Gene(s) 
The investigation of IGF gene structures in fish would extend the evolutionary 
picture for these hormones and facilitate our understanding of the features of the IGF 
genes that are common to all vertebrate species. 
The cloned common carp IGF-I gene, which is only about 13 kb in length, 
appears to be much more compact than the mammalian and avian counterpart. As in 
other species, however, the mature IGF-I peptide consists of 70 amino acids encoding 
by exons 2 and 3. 
Li the present study, we also found that the common carp IGF-I gene is 
interrupted by four exons with an additional potential splice donor site at the 3，end of 
E-peptide similar to the chum salmon IGF-I gene (Kavsan et al” 1993). This increases 
the complexity ofIGF-I gene expression and IGF-I biosynthesis in common carp. 
Li one of the ten isolated genomic clones, P6, the restriction pattem was found 
to be different from other genomic clones. However, it binds to the common carp 
conserved IGF-I cDNA probe and specific E-domain probe. Thus, this clone may be a 
subtype of the IGF-I gene. To confirm the presence of other related IGF-I genes, this 
clone may be a potential target. 
Li the search for IGF-H gene, we found that the common carp conserved IGF-I 
cDNA probe, presumably being able to bind to both IGF-I and IGF-H genes, can only 
detect IGF-I related genes but not others. It was confirmed by the screening of 
common carp genomic library and the liver cDNA library that only IGF-I gene or 
cDNA was found. However, the absence of positive signal in Southern analysis ofthe 
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common carp genomic DNA using the entire coding region of trout IGF-E cDNA may 
indicate the absence oflGF-E gene or the nucleotide sequence is totally different from 
other species. 
IGF-I Gene Expression Studies 
From the expression studies, we found that the chronic injection of GH to 
common carp did not increase but acute injection did slightly increase IGF-I mRNA 
level. This indicates that the clearance rate of GH might be very fast. Li addition, we 
have to modify the experimental design by increasing the sample size and using 
juvenile carps of larger size. Because the average weight of the juvenile common carp 
used is only 4 to 6 g so that the amount of the individual liver tissue is so little for 
preparing enough polyA+ mRNA for Northern analysis. However, using RT-PCR, we 
found that the dose of 100 ng/g could increase the IGF-I mRNA level in the liver of 
common carp. 
Conclusions 
(1) A DNA fragment of the common carp IGF-I promoter region was obtained 
byPCR. 
(2) A genomic clone of 13 kb was isolated from common carp. This clone 
carries the entire IGF-I gene which is found to be more compact than other known 
vertebrate IGF-I genes. 
(3) The gene structure of the common carp IGF-I is different from other 
species in the number of introns. 
(4) Using RT-PCR, IGF-I expression in common carp was found to be 
induced by GH administration. 
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